Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.2961432985365867e-35,19.590021825968783,1573.687710277887,"['RPL4', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",7.569476863453667e-33,0,0,73
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.5593869521448981e-16,6.036834292076452,219.72307259972507,"['COX7B', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'UCP1', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'UCP3', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'ATP5PO']",4.5534099002631025e-14,0,0,55
3,Oxidative phosphorylation WP623,1.1592064180823537e-09,5.751025348903446,118.33039567998048,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'ATP5PO']",2.2565884938669818e-07,0,0,31
4,"GPCRs, Class A Rhodopsin-like WP455",3.6822378444461316e-09,2.7032967032967035,52.49733306904029,"['NPFFR2', 'GPR27', 'OXTR', 'NPFFR1', 'CHRM1', 'PTGDR2', 'GPR68', 'GPR65', 'GPR22', 'NPY2R', 'GPR20', 'ADRA1D', 'MC4R', 'CYSLTR2', 'ADORA3', 'GPR171', 'CMKLR1', 'PTGDR', 'GPR35', 'OR2H2', 'SSTR1', 'SSTR3', 'TRHR', 'ADORA2A', 'ADORA2B', 'OR7A5', 'APLNR', 'OR3A3', 'OR3A2', 'CX3CR1', 'PTGER2', 'GPR87', 'CXCR5', 'OPRL1', 'CXCR4', 'GPR83', 'ADRB2', 'MCHR1', 'HRH1', 'OR2AG1', 'P2RY1', 'RHO', 'DRD2', 'DRD3', 'NTSR1', 'DRD5', 'CCR1', 'GPR17', 'GPR12', 'HTR1E', 'P2RY14', 'GPR52', 'GPR1', 'HTR1B', 'GPR4', 'GPR3', 'GPR6', 'HTR5A', 'HCRTR2', 'HCRTR1', 'MAS1', 'OPN1SW', 'ACKR4', 'RGL4', 'OR7C1', 'GPR18']",5.376067252891352e-07,0,0,66
5,Spinal Cord Injury WP2431,1.5626381176673306e-06,2.6778018352407464,35.79989440978762,"['C1QB', 'CDKN1B', 'XYLT1', 'CXCL1', 'CXCL2', 'RTN4', 'EGFR', 'AQP1', 'ICAM1', 'TNFSF13B', 'LGALS3', 'ACAN', 'GJA1', 'ZFP36', 'CHST11', 'PTPRZ1', 'MYC', 'E2F1', 'CCL2', 'SLIT3', 'SOX9', 'ROS1', 'MAPK3', 'NGFR', 'EGR1', 'IL1R1', 'GADD45A', 'BDNF', 'MIF', 'LILRB2', 'PDYN', 'SELP', 'NR4A1', 'VCAN', 'FCGR2A', 'IL1B', 'LEP', 'APEX1', 'CDK2', 'CDK1', 'CSPG4', 'LTB', 'VIM', 'TLR4']",0.0001825161321435442,0,0,44
6,Nonalcoholic fatty liver disease WP4396,1.8901098930216998e-06,2.3608607663248784,31.113490315564302,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'COX4I1', 'PRKAG2', 'COX6A1', 'COX7C', 'CASP7', 'LEPR', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'IL1B', 'PPARA', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CCL2', 'CYC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'VCAM1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'UQCRQ', 'LEP', 'CYCS', 'BAX']",0.0001839706962541121,0,0,54
7,Mitochondrial CIV Assembly WP4922,3.2730554922735882e-06,5.4072359658507825,68.29223638795688,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",0.0002730663439268251,0,0,19
8,Complement and Coagulation Cascades WP558,1.6715689930650217e-05,3.427795153697912,37.70287681308038,"['C1QB', 'C1QA', 'CPB2', 'SERPINA1', 'CFH', 'C1R', 'C5AR1', 'CFI', 'PLG', 'TFPI', 'THBD', 'C6', 'C7', 'C9', 'CR1', 'VWF', 'SERPIND1', 'F12', 'SERPINF2', 'F2', 'F5', 'F7', 'MASP2', 'KLKB1', 'C1QC']",0.0012202453649374659,0,0,25
9,Platelet-mediated interactions with vascular and circulating cells WP4462,0.00020050852179091222,7.385050962627407,62.8811523117188,"['SELP', 'VCAM1', 'SELPLG', 'IL1B', 'CCL2', 'TLR7', 'SELE', 'TLR4', 'ICAM1', 'TLR2']",0.013010775191765859,0,0,10
10,Nuclear Receptors Meta-Pathway WP2882,0.00022296793912348874,1.6451608319399775,13.833306176243978,"['SERPINA1', 'CDKN1B', 'SRXN1', 'SLC2A2', 'SLC2A3', 'SLC7A11', 'THBD', 'ZIC2', 'MYC', 'FTH1', 'SLCO2B1', 'ENC1', 'PDK4', 'CYP1B1', 'SLC39A7', 'SLC39A3', 'SRGN', 'HSP90AA1', 'SERPINB2', 'ABCC2', 'SLC2A10', 'GPX3', 'HGF', 'SLC2A12', 'MYOF', 'CYP4A11', 'SLC39A11', 'AIP', 'APOA1', 'SLC39A12', 'TGFBR2', 'TGFBR3', 'KAT2B', 'CYP2A6', 'CDC37', 'IL1B', 'AHRR', 'ANGPTL4', 'PPARA', 'EPHA2', 'FKBP5', 'FTL', 'NR1I3', 'AMIGO2', 'SLC5A12', 'TXN', 'SLC5A2', 'ABCB11', 'CYP2C19', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'EGFR', 'FOXO1', 'CYP3A7', 'PRRG4', 'FGD4', 'HMOX1', 'CCL2', 'STOM', 'HES1', 'IP6K3', 'CBR3', 'EGR1', 'GSTM2', 'JUN', 'GADD45B', 'SLC10A1', 'CAVIN2', 'PLK2', 'SOD3', 'NFKB2', 'SLC2A9', 'PSMC5', 'GSTA1', 'BHLHE40', 'CDK1', 'BAX', 'SPRY1', 'GSTM5']",0.013021327644811741,0,0,81
11,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0002706579814836685,2.906026785714286,23.872006288751734,"['NDUFA8', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'TMEM186', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.013971952831951453,0,0,22
12,Complement system WP2806,0.0002921123458034474,2.342131725945861,19.061139454995516,"['FKBP2', 'SELPLG', 'CFH', 'C1R', 'CFI', 'C5AR1', 'ICAM2', 'C4BPA', 'ADM', 'PLG', 'TXN', 'LRP2', 'ICAM1', 'FCGR3A', 'C6', 'RPS19', 'C7', 'C9', 'CD59', 'VSIG4', 'PRNP', 'CR1', 'CD93', 'F12', 'APOA1', 'SELE', 'SELP', 'MASP2', 'PTX3', 'KLKB1', 'TLR2']",0.013971952831951453,0,0,31
13,Glycolysis and Gluconeogenesis WP534,0.0003110194979715221,3.1929786081077594,25.785393512372107,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A2', 'SLC2A3', 'ENO2', 'GCK', 'LDHC', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'PFKM', 'GAPDH', 'FBP2']",0.013971952831951453,0,0,19
14,Apoptosis Modulation and Signaling WP1772,0.000548565692121622,2.1936055713833493,16.470037069398657,"['BCL2A1', 'CASP7', 'BCL2L10', 'CAPNS1', 'CASP6', 'CASP10', 'BAG3', 'CASP4', 'CASP1', 'TNFSF10', 'PMAIP1', 'FADD', 'MAPK3', 'JUN', 'ENDOG', 'CRADD', 'IL1R1', 'BAD', 'IL1R2', 'TNFRSF10C', 'TNFRSF10B', 'TNFRSF10A', 'CFLAR', 'TNFRSF1B', 'PTPN13', 'TNFRSF10D', 'TOLLIP', 'BCL2', 'CYCS', 'BAX', 'PRKD1', 'BCL2L2']",0.022883026014216233,0,0,32
15,Selenium Micronutrient Network WP15,0.0006812342587075294,2.302257636122178,16.787151722396334,"['SERPINA3', 'PLG', 'TXN', 'SELENOK', 'ICAM1', 'SELENOH', 'PRDX3', 'PRDX5', 'KYNU', 'RFK', 'PNPO', 'CCL2', 'SEPHS2', 'XDH', 'ABCA1', 'GPX4', 'GPX3', 'DIO3', 'APOA1', 'F2', 'KMO', 'SOD3', 'NFKB2', 'SOD1', 'F7', 'SELENOM', 'IL1B', 'SELENOW']",0.026522720472346478,0,0,28
16,Blood Clotting Cascade WP272,0.0008489626443506255,5.2742274712829635,37.296675155149515,"['F7', 'F8A1', 'SERPINB2', 'VWF', 'F12', 'SERPINF2', 'PLG', 'F2', 'KLKB1', 'F5']",0.03098713651879783,0,0,10
17,Proximal tubule transport WP4917,0.0010734144388234016,2.587872763419483,17.693054848857756,"['SLC47A2', 'ATP6V1G1', 'SLC22A6', 'ABCC2', 'SLC2A2', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'SLC5A2', 'SLC4A4', 'AQP1', 'SLC7A9', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0D2', 'ATP6V0C', 'ATP6V1D', 'ABCG2', 'ATP6V1B1', 'ATP6V1F']",0.0368749430748745,0,0,21
18,Microglia Pathogen Phagocytosis Pathway WP3937,0.0014927389464245466,2.8552546744036107,18.57954940390898,"['C1QB', 'VAV3', 'LYN', 'C1QA', 'FCER1G', 'NCF1', 'SYK', 'NCF4', 'PIK3R6', 'HCK', 'PLCG2', 'RAC3', 'NCKAP1L', 'PTPN6', 'FCGR1A', 'SIGLEC7', 'C1QC']",0.04843108581732973,0,0,17
19,Sleep regulation WP3591,0.0017476534421540777,3.2318948412698414,20.520855796939347,"['CHRNB2', 'OXTR', 'AHCY', 'NPY2R', 'HCRTR2', 'HCRTR1', 'STAR', 'ADORA2A', 'CRH', 'UTS2', 'GHRL', 'DRD2', 'DRD3', 'PTGDR']",0.053717347906209544,0,0,14
20,Cellular Proteostasis WP4918,0.00218440663174622,18.442182640655922,112.98439154779446,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.06378467364698961,0,0,5
21,Hematopoietic Stem Cell Differentiation WP2849,0.0023570469669131813,2.507613235473014,15.171927028380189,"['NOTCH1', 'CSF1', 'LEF1', 'RHOH', 'CXCR4', 'NFATC2', 'IKZF1', 'GATA2', 'GATA1', 'ABO', 'FLI1', 'RUNX1', 'LYL1', 'MUC1', 'TPO', 'IL5', 'IL1B', 'NCKAP1L', 'CD34']",0.06554835374653799,0,0,19
22,Heart Development WP1591,0.0025670958076184354,3.041549953314659,18.142784807787386,"['SMAD1', 'FOXC1', 'NOTCH1', 'NFATC3', 'VEGFC', 'NFATC2', 'NFATC1', 'TBX2', 'NFATC4', 'HEY1', 'HEY2', 'BHLHE40', 'SMYD1', 'FGF10']",0.06814472507496211,0,0,14
23,Role of Osx and miRNAs in tooth development WP3971,0.002924354737291176,6.456930693069307,37.67413357910822,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'ALPL', 'KLF4', 'BMP7', 'DKK1']",0.07425318115556725,0,0,7
24,White fat cell differentiation WP4149,0.003926513204625238,3.000194814395013,16.62108968903823,"['CEBPB', 'TCF7L1', 'EGR2', 'EBF1', 'RORA', 'GATA2', 'KLF4', 'KLF15', 'FOXO1', 'KLF2', 'MECOM', 'DDIT3', 'ZNF423']",0.09554515464588079,0,0,13
25,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.004117615297358991,4.151960090574582,22.804562302671123,"['TCF7L2', 'TCF7L1', 'VCAM1', 'NOTCH1', 'EPAS1', 'LEF1', 'TCF7', 'CXCR4', 'CYTIP']",0.09617855939883492,0,0,9
26,Imatinib and Chronic Myeloid Leukemia WP3640,0.004281922165016623,3.6911098527746318,20.12892597164077,"['PDGFRA', 'CSF1R', 'LYL1', 'SPRED2', 'CDKN1B', 'FLT1', 'GADD45A', 'MYC', 'PIM2', 'ABCG2']",0.09617855939883492,0,0,10
27,Computational Model of Aerobic Glycolysis WP4629,0.005729183429637211,5.165148514851485,26.663438066313766,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.12392011566326412,0,0,7
28,Mitochondrial complex III assembly WP4921,0.006444741794009464,4.216994098148597,21.27258753699787,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.13346146846780335,0,0,8
29,Differentiation of white and brown adipocyte WP2895,0.00662736744103818,3.3552970246061977,16.83200730772216,"['PLAC8', 'SMAD1', 'CEBPB', 'LEP', 'ZIC1', 'PRDM16', 'EBF3', 'SLC7A10', 'ZNF423', 'BMP7']",0.13346146846780335,0,0,10
30,Aryl Hydrocarbon Receptor Pathway WP2873,0.007777869554744104,2.666430528006045,12.949447370862107,"['HSP90AA1', 'JUN', 'CDKN1B', 'SERPINB2', 'MYOF', 'AIP', 'EGFR', 'CDC37', 'IL1B', 'CYP1B1', 'AHRR', 'BAX', 'HES1']",0.14892577325555176,0,0,13
31,"GPCRs, Other WP117",0.007905306457058397,1.9765921872625019,9.567143095402342,"['GPR17', 'ADGRV1', 'GPR88', 'GPR55', 'ADRA1D', 'GPR83', 'ADRB2', 'GPR84', 'ADGRE2', 'PROKR2', 'SMO', 'ADORA2A', 'ADORA3', 'HRH4', 'GNRHR', 'S1PR1', 'OR10A2', 'LGR6', 'OR3A3', 'DRD3', 'NTSR1', 'GPR18', 'GPR135']",0.14892577325555176,0,0,23
32,Vitamin B12 metabolism WP1533,0.00849081466799889,2.408254336115186,11.484411818124872,"['ABCA1', 'SERPINA3', 'CUBN', 'APOA1', 'PLG', 'LRP2', 'F2', 'SOD3', 'ICAM1', 'NFKB2', 'SOD1', 'F7', 'TCN1', 'IL1B', 'CCL2']",0.15495736769097973,0,0,15
33,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.00890164490231413,5.532946832579186,26.123914696164288,"['SOCS3', 'CDH1', 'MYC', 'E2F1', 'CHI3L1', 'BAX']",0.15753214008943792,0,0,6
34,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.009856890058349362,3.075453001132503,14.207315229864097,"['GSK3A', 'BCL2L10', 'BCL2A1', 'ITGB4', 'MYC', 'BCL2', 'BAX', 'ITGA6', 'BCL2L14', 'BCL2L2']",0.16930658217870667,0,0,10
35,Folate Metabolism WP176,0.011133703707215835,2.164891171435559,9.737200751627352,"['ABCA1', 'SERPINA3', 'AHCY', 'CSF1', 'GPX4', 'GPX3', 'APOA1', 'PLG', 'F2', 'SOD3', 'ICAM1', 'NFKB2', 'SOD1', 'F7', 'RFK', 'IL1B', 'CCL2']",0.18577379900040136,0,0,17
36,Peptide GPCRs WP24,0.012320524709444227,2.0774510499432464,9.133490131799054,"['CX3CR1', 'CCR1', 'OXTR', 'NPY2R', 'C5AR1', 'TACR2', 'CXCR5', 'OPRL1', 'CXCR4', 'SSTR1', 'SSTR3', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'GNRHR', 'TAC4', 'NTSR1']",0.1998662897309841,0,0,18
37,Pre-implantation embryo WP3527,0.01435968127346001,2.2152537567337682,9.40005474176778,"['EGR1', 'DLX2', 'TCF7L1', 'FOXD1', 'HMGA1', 'ATP1A1', 'GATA2', 'KLF4', 'AQP3', 'TBX3', 'ZFP36', 'ARGFX', 'CDH1', 'DDIT3', 'SIX3']",0.2266501044243418,0,0,15
38,IL-18 signaling pathway WP4754,0.015450639573230873,1.4051659353712638,5.859689324539738,"['SPON1', 'NCF1', 'HSPB1', 'RND2', 'CXCL2', 'ICAM1', 'EPS8', 'PPP1R13L', 'TMSB4X', 'FAM186B', 'STMN1', 'NPPA', 'TGM2', 'TICAM2', 'USP5', 'IMP3', 'MMP2', 'NDUFC1', 'BPGM', 'ARL4D', 'ACTA1', 'MMP14', 'IL1B', 'LTB', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'SDC4', 'TSHZ1', 'COX17', 'GATA1', 'ACACB', 'FUT1', 'SOCS3', 'PTPRZ1', 'HMOX1', 'CCL2', 'FADD', 'MAPK3', 'SLC12A3', 'JUN', 'BAD', 'CFLAR', 'KLF2', 'NFATC4', 'NFKB2', 'COL1A1', 'NR4A1', 'COL1A2', 'NACA', 'BCL2', 'CYCS', 'BAX', 'PTX3', 'PTPN7', 'NFKBIE', 'NOX1', 'IL18R1', 'CDK5R2', 'SNTB1', 'ITM2C']",0.2361939724587411,0,0,63
39,Cancer immunotherapy by PD-1 blockade WP4585,0.016177669346489117,3.279381248820977,13.524573021412035,"['JUN', 'CD8B', 'NFATC3', 'NFATC2', 'NFATC1', 'PDCD1LG2', 'BATF', 'NFATC4']",0.2361939724587411,0,0,8
40,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.016177669346489117,3.279381248820977,13.524573021412035,"['JUN', 'TIFA', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR4', 'TLR2']",0.2361939724587411,0,0,8
41,Cytokines and Inflammatory Response WP530,0.016591020513766545,3.6888260254596887,15.120105619231854,"['IL5', 'CSF1', 'IL15', 'IL7', 'IL1B', 'CXCL1', 'CXCL2']",0.23632087756194298,0,0,7
42,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.017718917149862762,2.5371884735202492,10.232791778726435,"['VCAM1', 'BCL2A1', 'MMP2', 'IL1B', 'CFLAR', 'CXCL2', 'SELE', 'BCL2L2', 'ICAM1', 'RELB', 'NFKB2']",0.24637732417904412,0,0,11
43,Glucocorticoid Receptor Pathway WP2880,0.018454400535786133,1.8467764839534224,7.373167252735051,"['SRGN', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'CAVIN2', 'NR1I3', 'PLK2', 'AMIGO2', 'NFKB2', 'TGFBR3', 'PRRG4', 'THBD', 'FGD4', 'ZIC2', 'ENC1', 'BHLHE40', 'CCL2', 'STOM', 'SPRY1', 'ANGPTL4']",0.25063650960230466,0,0,21
44,Lung fibrosis WP3624,0.020048505829565744,2.0369667690261504,7.963726604666568,"['DSP', 'EDN1', 'CEBPB', 'SERPINA1', 'HGF', 'MMP2', 'FAM13A', 'CXCL2', 'FGF2', 'BMP7', 'CYSLTR2', 'IL5', 'IL1B', 'HMOX1', 'CCL2', 'PTX3']",0.26609835010150895,0,0,16
45,Thyroxine (Thyroid Hormone) Production WP1981,0.021451041606243868,7.374222724703222,28.331631525776324,"['TPO', 'TG', 'TRH', 'CGA']",0.2783868510676982,0,0,4
46,Complement Activation WP545,0.02376827253166334,2.95121675155631,11.035790765193973,"['C1QB', 'C1QA', 'C6', 'C7', 'C1R', 'C9', 'MASP2', 'C1QC']",0.28572369494833794,0,0,8
47,Nanomaterial induced apoptosis WP2507,0.02376827253166334,2.95121675155631,11.035790765193973,"['CASP7', 'ENDOG', 'CASP6', 'BCL2', 'BAX', 'CYCS', 'CFLAR', 'FADD']",0.28572369494833794,0,0,8
48,TP53 network WP1742,0.02376827253166334,2.95121675155631,11.035790765193973,"['CDKN1A', 'SUMO1', 'GADD45A', 'MYC', 'TNFSF10', 'BCL2', 'PMAIP1', 'BAX']",0.28572369494833794,0,0,8
49,TYROBP causal network in microglia WP3945,0.024242460301950607,1.8462957706500143,6.86757337153992,"['CD84', 'RBM47', 'GIMAP2', 'RNASE6', 'SLC1A5', 'LHFPL2', 'TNFRSF1B', 'RUNX3', 'SAMSN1', 'APBB1IP', 'LYL1', 'ADAP2', 'ELF4', 'DPYD', 'HCLS1', 'NCKAP1L', 'TMEM106A', 'IL13RA1', 'C1QC']",0.28572369494833794,0,0,19
50,Cori Cycle WP1946,0.025469029227210897,3.2274752475247523,11.845776920327049,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'SLC2A2', 'ALDOA', 'GAPDH']",0.28572369494833794,0,0,7
51,Development and heterogeneity of the ILC family WP3893,0.025469029227210897,3.2274752475247523,11.845776920327049,"['IL33', 'IL5', 'NFIL3', 'IL15', 'IL7', 'IL1B', 'RORA']",0.28572369494833794,0,0,7
52,Fatty Acid Omega Oxidation WP206,0.02571214419187817,4.609485439638111,16.874366785629626,"['CYP2A6', 'ADH1B', 'CYP4A11', 'ALDH1A1', 'CYP3A4']",0.28572369494833794,0,0,5
53,EDA signaling in hair follicle development WP3930,0.026419656724675084,3.6880656108597285,13.40112844306092,"['EDA', 'SOSTDC1', 'LTB', 'GLI1', 'DKK1', 'RELB']",0.28572369494833794,0,0,6
54,Transcriptional cascade regulating adipogenesis WP4211,0.026419656724675084,3.6880656108597285,13.40112844306092,"['CEBPB', 'EGR2', 'DDIT3', 'GATA2', 'KLF15', 'KLF2']",0.28572369494833794,0,0,6
55,Oxidation by Cytochrome P450 WP43,0.028474658924258385,1.977449471424521,7.037230010669259,"['CYP2J2', 'CYP4A11', 'CYP3A43', 'CYP3A4', 'CYP2C19', 'CYP4F11', 'CYP3A5', 'CYP2C18', 'CYP3A7', 'CYP39A1', 'CYP26A1', 'CYP26B1', 'CYP2A6', 'CYP11A1', 'CYP1B1']",0.30234910566848905,0,0,15
56,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.029359257212154787,1.4710743560912805,5.1901671276811205,"['TPH1', 'DLX2', 'CEBPB', 'YWHAB', 'CDCA7L', 'ATP1A3', 'RORA', 'ECE1', 'GATA2', 'FOXM1', 'GJA1', 'HES1', 'PKNOX1', 'TAC1', 'YWHAG', 'HES5', 'YWHAH', 'NKX3-1', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'TSPYL1', 'CAV3', 'BDNF', 'SSTR1', 'RUNX3', 'GCK', 'NFKB2', 'ADCYAP1', 'PRKAR1A', 'SST', 'IL1B', 'BHLHE40', 'CHRFAM7A', 'AVP', 'ALDOA', 'GAPDH', 'SLC25A4']",0.3061751109267571,0,0,39
57,Gastric acid production WP2596,0.032682615954689936,11.059056230573608,37.832057776583895,"['CCK', 'VIP', 'MUC6']",0.3290099704206653,0,0,3
58,Metapathway biotransformation Phase I and II WP702,0.03323089248727378,1.4703971285260689,5.0056366833227885,"['GLYAT', 'CYP2C19', 'CYP3A4', 'CYP2C18', 'CYP3A5', 'NAA80', 'CYP3A7', 'SULT1C2', 'CYP26B1', 'CHST11', 'CYP11A1', 'CYP1B1', 'CHST13', 'CHST14', 'GAL3ST2', 'SULT4A1', 'SULT1A2', 'CYP2J2', 'CHST8', 'GSTM2', 'GPX4', 'GPX3', 'EPHX1', 'CYP3A43', 'KCNAB1', 'FMO2', 'CYP4F11', 'HS3ST4', 'CYP39A1', 'CYP26A1', 'SULT1B1', 'CYP2A6', 'GSTA1', 'NAT8L', 'CHST2', 'GSTM5', 'CHST3']",0.3290099704206653,0,0,37
59,Kynurenine Pathway and links to Cellular Senescence WP5044,0.03354031835241603,2.6827185265215827,9.1078482594888,"['CDKN1A', 'IL1R2', 'HAAO', 'KYNU', 'KMO', 'TLR4', 'FOXO1', 'ACMSD']",0.3290099704206653,0,0,8
60,NRF2 pathway WP2884,0.033802394221301234,1.4957036976706304,5.066282929246113,"['SERPINA1', 'SRXN1', 'SLC2A2', 'SLC5A12', 'SLC2A3', 'TXN', 'SLC7A11', 'SLC5A2', 'SLC5A3', 'SLC5A4', 'FTH1', 'HMOX1', 'SLC39A7', 'SLC39A3', 'CBR3', 'EGR1', 'GSTM2', 'HSP90AA1', 'ABCC2', 'GPX3', 'SLC2A10', 'HGF', 'CYP4A11', 'SLC2A12', 'SLC39A11', 'SLC39A12', 'SOD3', 'TGFBR2', 'SLC2A9', 'CYP2A6', 'GSTA1', 'FTL', 'EPHA2', 'GSTM5']",0.3290099704206653,0,0,34
61,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.03531424456887236,2.3058819365798415,7.709644467259454,"['RAB3B', 'FGD4', 'EGR2', 'RAB3A', 'RAB25', 'HSPB1', 'NEFL', 'MFN2', 'RABAC1', 'RAB11A']",0.3380904725937944,0,0,10
62,Toll-like Receptor Signaling related to MyD88 WP3858,0.039731597797408404,2.1360878832595507,6.890183219250561,"['TICAM2', 'TOLLIP', 'IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR5', 'TLR4', 'RELB', 'NFKB2', 'TLR2']",0.35722601044074576,0,0,11
63,Myometrial relaxation and contraction pathways WP289,0.03990362785025011,1.4214954092167114,4.57904615444752,"['RYR1', 'OXTR', 'RAMP2', 'RGS14', 'YWHAB', 'ADCY4', 'ITPR2', 'ADM', 'RXFP2', 'ETS2', 'RYR3', 'ACTG1', 'RGS4', 'CNN2', 'GJA1', 'GNG3', 'PLCG2', 'RGS20', 'SFN', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP2', 'GNG12', 'GNG11', 'CREB3', 'ACTA1', 'ADCY9', 'ACTC1', 'PRKAR1A', 'IL1B', 'CRH', 'RGS10', 'CALM3', 'PRKD1', 'CALM1', 'CALM2']",0.35722601044074576,0,0,40
64,Aryl Hydrocarbon Receptor Netpath WP2586,0.040217879541969176,1.9135802469135803,6.149182231037796,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'LPL', 'EGFR', 'HPGDS', 'MYC', 'CDC37', 'CDK2', 'E2F1', 'CYP1B1', 'AHRR', 'HRAS']",0.35722601044074576,0,0,14
65,Constitutive Androstane Receptor Pathway WP2875,0.04021982435134919,2.371456875985605,7.620428288959176,"['HSP90AA1', 'CYP2A6', 'ABCC2', 'NR1I3', 'CYP4A11', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1']",0.35722601044074576,0,0,9
66,Farnesoid X receptor pathway WP2879,0.04037143268679661,3.160956690368455,10.145510449323545,"['SLC10A1', 'SLCO2B1', 'CYP3A4', 'ABCB11', 'IP6K3', 'FKBP5']",0.35722601044074576,0,0,6
67,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.041659205313890356,4.915771622385528,15.623467191814187,"['CD86', 'IL5', 'CD80', 'VIP']",0.35777905740164656,0,0,4
68,Nanomaterial-induced inflammasome activation WP3890,0.041659205313890356,4.915771622385528,15.623467191814187,"['IL1B', 'CASP1', 'TLR4', 'NOX1']",0.35777905740164656,0,0,4
69,Tamoxifen metabolism WP691,0.04252266892239166,3.687305626236924,11.643471195709392,"['CYP2A6', 'CYP1B1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.35865636474969625,0,0,5
70,Adipogenesis WP236,0.04298963276109373,1.4777207977207978,4.650086325307865,"['CDKN1A', 'CEBPB', 'EPAS1', 'UCP1', 'LPL', 'RORA', 'GATA2', 'FOXO1', 'SOCS3', 'CYP26B1', 'E2F1', 'NDN', 'RXRG', 'GDF10', 'WWTR1', 'EGR2', 'GADD45B', 'GADD45A', 'EBF1', 'HMGA1', 'LIFR', 'MIF', 'PRLR', 'KLF15', 'SFRP4', 'CYP26A1', 'DDIT3', 'LEP', 'ID3', 'PLIN2', 'PPARA', 'LPIN3']",0.35865636474969625,0,0,32
71,Oxidative Damage WP3941,0.0463939953322734,1.9187985264947578,5.891834432197602,"['C1QB', 'C1QA', 'CDKN1A', 'CDKN1B', 'C1R', 'BAD', 'GADD45A', 'C5AR1', 'TNFRSF1B', 'BCL2', 'CYCS', 'NFKBIE', 'C1QC']",0.3816069475217981,0,0,13
72,Pregnane X receptor pathway WP2876,0.05252248580074664,2.213189923577696,6.5211948734108995,"['HSP90AA1', 'PSMC5', 'CYP2A6', 'ABCC2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1', 'CYP3A7']",0.42601571816161166,0,0,9
73,Cells and molecules involved in local acute inflammatory response  WP4493,0.058206760203879784,2.765625,7.864756537536383,"['SELP', 'VCAM1', 'SELPLG', 'C6', 'C7', 'ICAM1']",0.4644759810257603,0,0,6
74,Exercise-induced Circadian Regulation WP410,0.06044465706283015,1.7297366742273887,4.853687969709135,"['IDI1', 'HSPA8', 'CEBPB', 'BTG1', 'GFRA1', 'QKI', 'PER2', 'DNAJA1', 'CLDN5', 'SUMO1', 'TUBB3', 'STBD1', 'UCP3', 'SUMO3', 'EIF4G2']",0.4644759810257603,0,0,15
75,Globo Sphingolipid Metabolism WP1424,0.0604455043800647,2.2696443341604633,6.368651674794912,"['B3GALNT1', 'ST6GAL2', 'B3GALT5', 'FUT2', 'ST6GALNAC3', 'A4GALT', 'FUT1', 'ABO']",0.4644759810257603,0,0,8
76,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.0604455043800647,2.2696443341604633,6.368651674794912,"['CD86', 'IL4R', 'CD80', 'CCL2', 'TLR7', 'TLR4', 'NFKB2', 'TGFBR2']",0.4644759810257603,0,0,8
77,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.06456290765880683,3.072519083969466,8.419056299423517,"['HSD11B1', 'HSD11B2', 'STAR', 'CYP11A1', 'HSD3B1']",0.4833940778556819,0,0,5
78,Glycolysis in senescence WP5049,0.06456290765880683,3.072519083969466,8.419056299423517,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'GAPDH']",0.4833940778556819,0,0,5
79,Breast cancer pathway WP4262,0.06630451985051344,1.3628585361528571,3.6981128373921592,"['NOTCH2', 'NOTCH3', 'CDKN1A', 'NOTCH1', 'TCF7', 'LEF1', 'LRP5', 'FGF2', 'EGFR', 'DLL3', 'FRAT1', 'FRAT2', 'HEY1', 'MYC', 'HEY2', 'E2F1', 'HES1', 'HRAS', 'HES5', 'SKP1', 'MAPK3', 'TCF7L2', 'WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'GADD45B', 'GADD45A', 'CSNK2A3', 'WNT16', 'NFKB2', 'FGF17', 'SFRP4', 'HEYL', 'RAD51', 'BAX', 'PGR', 'FGF10']",0.4893963797344515,0,0,38
80,Canonical and non-canonical Notch signaling WP3845,0.06704059996362349,2.0747063402207755,5.606804409645024,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'MAML2', 'HEY1', 'LEF1', 'HES1', 'DLL3', 'DLK2']",0.4893963797344515,0,0,9
81,PI3K-Akt signaling pathway WP4172,0.0692543144970063,1.238382687023466,3.3064444156281882,"['CDKN1A', 'CDKN1B', 'CHRM1', 'FLT1', 'CSF1', 'ITGB5', 'ITGB4', 'FGF2', 'GYS2', 'GYS1', 'CCND3', 'MYC', 'CREB3L1', 'TNR', 'ITGB8', 'HRAS', 'PDGFRA', 'HSP90AA1', 'IL4R', 'SYK', 'VWF', 'HGF', 'OSMR', 'PRLR', 'CREB3', 'CDC37', 'COL4A6', 'ITGA8', 'ITGA6', 'COL6A6', 'COL6A5', 'SGK1', 'TLR4', 'EPHA2', 'TLR2', 'CSF1R', 'PHLPP1', 'PKN3', 'LAMA1', 'LPAR3', 'PIK3R6', 'EGFR', 'THBS4', 'PIK3R5', 'GNG10', 'GNG3', 'PDGFC', 'NTF3', 'MAPK3', 'NTRK1', 'NGFR', 'ANGPT2', 'LAMB3', 'BDNF', 'LAMB2', 'BAD', 'LAMB4', 'VEGFC', 'GNG12', 'GNG11', 'COL1A1', 'FGF17', 'EFNA3', 'COL1A2', 'IL7', 'ITGA10', 'CDK2', 'COL9A1', 'BCL2', 'FGFR4', 'PIK3AP1', 'FGFR3', 'FGF10']",0.4955219012281093,0,0,73
82,BMP Signaling Pathway in Eyelid Development WP3927,0.0695767053094263,2.3467146714671467,6.254758364723678,"['SMAD1', 'FOXC1', 'JUN', 'NOTCH1', 'EGFR', 'MAPK3', 'FGF10']",0.4955219012281093,0,0,7
83,Inflammatory Response Pathway WP453,0.07783075036910389,2.107365187161452,5.380564154968239,"['CD86', 'COL1A1', 'IL4R', 'COL1A2', 'IL5', 'LAMB2', 'CD80', 'TNFRSF1B']",0.5434726465640268,0,0,8
84,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.07862960873289827,1.7706968838526913,4.502894480289339,"['NDUFA13', 'CASP7', 'HSP90AA1', 'ACAP1', 'CASP5', 'IL1B', 'CASP1', 'CARD6', 'ERBIN', 'NLRC4', 'NOD2', 'AAMP']",0.5434726465640268,0,0,12
85,Drug Induction of Bile Acid Pathway WP2289,0.0800319308296341,2.4581447963800906,6.207625787290878,"['ABCC2', 'SLC10A1', 'NR1I3', 'SLC51A', 'CYP3A4', 'ABCB11']",0.5434726465640268,0,0,6
86,ERK Pathway in Huntington's Disease WP3853,0.0800319308296341,2.4581447963800906,6.207625787290878,"['CASP7', 'RPS6KA5', 'BDNF', 'ELK1', 'HRAS', 'EGFR']",0.5434726465640268,0,0,6
87,Purinergic signaling WP4900,0.08383691534970227,1.95251494314114,4.840053856737286,"['P2RY8', 'P2RX7', 'ADORA2A', 'GNAT3', 'ADORA2B', 'ADORA3', 'P2RY14', 'P2RX1', 'P2RY1']",0.5627673398186911,0,0,9
88,Monoamine GPCRs WP58,0.08819432581975481,1.8441392978482447,4.4779623735146865,"['HRH1', 'CHRM1', 'HTR1E', 'HTR1B', 'ADRA1D', 'ADRB2', 'DRD2', 'HTR5A', 'DRD3', 'DRD5']",0.5852896168038274,0,0,10
89,VEGFA-VEGFR2 Signaling Pathway WP3888,0.09003938281803851,1.1781218888440657,2.8363380107941523,"['NCF1', 'ARPC5L', 'RPL10A', 'ELK1', 'RPL7', 'ICAM1', 'ACTG1', 'TUBB8', 'CDH5', 'GJA1', 'RPS6KA5', 'RPL18A', 'CFL1', 'CHAC1', 'ATP6V1E1', 'IER5', 'TMSB10', 'SARS', 'DKK1', 'KATNAL2', 'TXNIP', 'PRKD2', 'RPL27', 'PRKD1', 'RPL26', 'ERG', 'EZR', 'ATP6V0D1', 'DSC1', 'EPHA2', 'SET', 'TXN', 'ADRB2', 'GATA2', 'ACACB', 'FUT1', 'FOXO1', 'LDHA', 'PGK1', 'IGFBP7', 'FADD', 'EGR1', 'JUN', 'SDF2L1', 'EGR3', 'TNFRSF10C', 'NFATC2', 'NFATC1', 'BMX', 'SELE', 'QKI', 'MOV10', 'NR4A1', 'NR4A3', 'BCL2', 'CYCS', 'EIF4G2', 'FLT1', 'ITGB5', 'HSPB1', 'RND1', 'TUBA1C', 'TMSB4X', 'RPLP2', 'ELOC', 'ADAMTS9', 'CLIC1', 'HRAS', 'CGNL1', 'PRKG1', 'DUSP5', 'HSP90AA1', 'SSR4', 'MMP2', 'GAB1', 'RPL13A', 'EPN1', 'MMP14', 'RCN1', 'TAL1', 'RHOJ', 'ALDOA', 'GAPDH', 'FJX1', 'ARF6', 'KANK1', 'APOLD1', 'PTPRZ1', 'AP2S1', 'S1PR1', 'CCL2', 'DNAJB9', 'CCT7', 'ABCF2', 'SLC25A25', 'MAPK3', 'RAB11A', 'DNAJA1', 'FMNL3', 'PTPN6']",0.5908202198397134,0,0,100
90,Endochondral Ossification with Skeletal Dysplasias WP4808,0.09623174980104811,1.5298529666147724,3.5813795779045785,"['HMGCS1', 'PTH1R', 'CTSV', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'ACAN', 'SCIN', 'CHST11', 'ALPL', 'SOX9', 'CALM1', 'CALM2', 'FGFR3', 'SOX5', 'DDR2']",0.6175751855363967,0,0,17
91,Endochondral Ossification WP474,0.09623174980104811,1.5298529666147724,3.5813795779045785,"['HMGCS1', 'PTH1R', 'CTSV', 'FGF2', 'RUNX3', 'BMP7', 'GLI3', 'ACAN', 'SCIN', 'CHST11', 'ALPL', 'SOX9', 'CALM1', 'CALM2', 'FGFR3', 'SOX5', 'DDR2']",0.6175751855363967,0,0,17
92,Vitamin D Receptor Pathway WP2877,0.09745550263237804,1.3161482719863544,3.0644661856197275,"['COLEC11', 'CDKN1A', 'STEAP4', 'CDKN1B', 'COL13A1', 'HILPDA', 'LRP5', 'ADRB2', 'CLDN2', 'CYP3A4', 'CYP3A5', 'FOXO1', 'THBD', 'SULT1C2', 'IL1RL1', 'CASP5', 'CLMN', 'MYC', 'CREG2', 'TIMP2', 'SOSTDC1', 'CA9', 'LGALS9', 'EPHB4', 'CDKN2D', 'GADD45A', 'NFATC2', 'KLF4', 'CEACAM1', 'BCL6', 'CDK2', 'PNOC', 'S100A6', 'S100A4', 'S100A8', 'NOX1']",0.6186305819272693,0,0,36
93,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.10292315827665144,1.8439003679592414,4.1926101436143535,"['CNTF', 'IL1B', 'CXCL1', 'SOX9', 'CXCL2', 'FGF2', 'MYT1', 'GLI2', 'SOX5']",0.6226799980516533,0,0,9
94,Bile acids synthesis and enterohepatic circulation  WP4389,0.10449082159085962,2.9490107405313735,6.660800930271275,"['SLC10A1', 'FGFR4', 'ABCB11', 'MAPK3']",0.6226799980516533,0,0,4
95,Estrogen Receptor Pathway WP2881,0.10449082159085962,2.9490107405313735,6.660800930271275,"['JUN', 'PDK4', 'CYP1B1', 'PPARA']",0.6226799980516533,0,0,4
96,Irinotecan pathway WP229,0.10449082159085962,2.9490107405313735,6.660800930271275,"['ABCC2', 'CYP3A4', 'CYP3A5', 'ABCG2']",0.6226799980516533,0,0,4
97,Nucleotide GPCRs WP80,0.10449082159085962,2.9490107405313735,6.660800930271275,"['ADORA2A', 'ADORA2B', 'ADORA3', 'P2RY1']",0.6226799980516533,0,0,4
98,PTF1A related regulatory pathway WP4147,0.10449082159085962,2.9490107405313735,6.660800930271275,"['KAT2B', 'NOTCH1', 'HES1', 'FGF10']",0.6226799980516533,0,0,4
99,Endometrial cancer WP4155,0.10852421066293191,1.475822928490352,3.2774809817073995,"['TCF7L2', 'CDKN1A', 'TCF7L1', 'GADD45B', 'BAD', 'GADD45A', 'LEF1', 'TCF7', 'FGF2', 'ELK1', 'EGFR', 'CDH1', 'MYC', 'BAX', 'CTNNA2', 'HRAS', 'FGFR3', 'MAPK3']",0.6401832224964872,0,0,18
100,Netrin-UNC5B signaling pathway WP4747,0.11090128338632242,1.5649350649350648,3.441471881473988,"['YAP1', 'ROBO4', 'JUN', 'VCAM1', 'ITGB4', 'SELE', 'ICAM1', 'COL1A1', 'CDH5', 'DCSTAMP', 'INPP5D', 'CCL2', 'ALPL', 'MAPK3']",0.6461489758758377,0,0,14
101,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.1161423693538622,3.6857869454648204,7.935272685520748,"['CYP2J2', 'COX8A', 'COX5A']",0.6461489758758377,0,0,3
102,Composition of Lipid Particles WP3601,0.1161423693538622,3.6857869454648204,7.935272685520748,"['APOA1', 'LPL', 'LCAT']",0.6461489758758377,0,0,3
103,let-7 inhibition of ES cell reprogramming WP3299,0.1161423693538622,3.6857869454648204,7.935272685520748,"['EGR1', 'MYC', 'KLF4']",0.6461489758758377,0,0,3
104,Apoptosis WP254,0.11707878816793142,1.4088559551780229,3.0218666453372527,"['JUN', 'CRADD', 'BAD', 'TNFRSF10B', 'CFLAR', 'TNFRSF1B', 'CASP7', 'CASP6', 'CASP10', 'MYC', 'CASP4', 'CASP1', 'TNFSF10', 'IRF7', 'BCL2', 'PMAIP1', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2']",0.6461489758758377,0,0,21
105,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.11707878816793142,1.4088559551780229,3.0218666453372527,"['TCF7L2', 'TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'SERPINF1', 'LEF1', 'TCF7', 'LRP5', 'WNT16', 'KLF4', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'WIF1', 'MYC']",0.6461489758758377,0,0,21
106,"COVID-19, thrombosis and anticoagulation WP4927",0.11728046479938152,7.3706214689265535,15.796620686761491,"['PLG', 'F2']",0.6461489758758377,0,0,2
107,Unfolded protein response WP4925,0.12057364754154702,1.8436615732880588,3.9002559731490978,"['XBP1', 'HSPA5', 'IL1B', 'DDIT3', 'BCL2', 'TNFRSF10B', 'PMAIP1', 'TXNIP']",0.6533782223799264,0,0,8
108,Pathways Regulating Hippo Signaling WP4540,0.12083021920724667,1.356750405593002,2.8673140657950755,"['CSF1R', 'FLT1', 'TCF7', 'LEF1', 'PRKAG2', 'EGFR', 'CDH5', 'CDH4', 'CDH1', 'CDH20', 'TEAD2', 'TEAD3', 'NTRK1', 'PDGFRA', 'NGFR', 'TCF7L2', 'TCF7L1', 'PRKCH', 'LATS2', 'PRKAR1A', 'CDH11', 'FGFR4', 'FGFR3', 'CDH17', 'EPHA2']",0.6533782223799264,0,0,25
109,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.12395604431297533,2.3040359061351428,4.810431271278947,"['ABCA1', 'LPL', 'APOA1', 'LCAT', 'LDLRAP1']",0.664128420147791,0,0,5
110,Neural Crest Differentiation WP2064,0.12543620985173448,1.3688593717056716,2.841694478241484,"['NOTCH2', 'NOTCH3', 'SMAD1', 'TCF7L1', 'NOTCH1', 'MIA', 'WNT8A', 'ZIC5', 'TBX6', 'FGF2', 'BMP7', 'NFKB2', 'DLL3', 'CDH1', 'MYC', 'HEY2', 'ZIC1', 'HES1', 'SOX9', 'MSX1', 'FGFR3', 'HES5', 'SOX5']",0.664128420147791,0,0,23
111,Phosphodiesterases in neuronal function WP4222,0.1263107753645684,1.495413757959831,3.0940259260888734,"['PDE6H', 'ADCY4', 'GRIN2C', 'ADCY10', 'ADCY9', 'PDE10A', 'ADORA2A', 'PDE3A', 'PDE6C', 'PDE5A', 'CHRFAM7A', 'PDE6A', 'PDE7B', 'DRD2', 'PDE9A']",0.664128420147791,0,0,15
112,Vitamin A and carotenoid metabolism WP716,0.12803212692608873,1.5806151355726425,3.2489134020238515,"['CYP26A1', 'ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'NPC1L1', 'ALDH1A1', 'LPL', 'LRAT', 'BCO1', 'RXRG']",0.664128420147791,0,0,12
113,Circadian rhythm related genes WP3594,0.12850430047380204,1.2401939603437515,2.5446211729788226,"['TPH1', 'MAGEL2', 'PHLPP1', 'AHCY', 'CHRM1', 'SUV39H1', 'NPY2R', 'OPRL1', 'RBM4B', 'RORA', 'RELB', 'ATOH7', 'PROKR2', 'NFIL3', 'SIX3', 'RPS27A', 'DRD2', 'DRD3', 'SKP1', 'CHRNB2', 'KLF10', 'NTRK1', 'EGR1', 'NGFR', 'JUN', 'ZFHX3', 'EGR3', 'HOMER1', 'CARTPT', 'HCRTR2', 'HCRTR1', 'PER2', 'F7', 'STAR', 'ADORA2A', 'LEP', 'BHLHE40', 'CRH', 'ID3', 'UTS2', 'GHRL', 'AVP', 'PPARA', 'UBA52']",0.664128420147791,0,0,44
114,Hippo-Merlin Signaling Dysregulation WP4541,0.13319758222048464,1.3052043628890602,2.6311897622397984,"['CSF1R', 'FLT1', 'ITGB5', 'ITGB4', 'FOXM1', 'EGFR', 'CDH5', 'CDH4', 'CDH1', 'CDH20', 'MYC', 'ITGB8', 'HRAS', 'TEAD2', 'TEAD3', 'NTRK1', 'PDGFRA', 'NGFR', 'LATS2', 'PRKAR1A', 'ITGA10', 'CDH11', 'ITGA8', 'ITGA6', 'FGFR4', 'FGFR3', 'CDH17', 'CD44', 'EPHA2']",0.6823455089189739,0,0,29
115,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.13525228069336295,2.0109008638420405,4.023035412549216,"['HSPB1', 'PDLIM5', 'TLR4', 'EGFR', 'ETS2', 'SOD1']",0.6868463645645562,0,0,6
116,IL1 and megakaryocytes in obesity WP2865,0.1419275527332055,1.8434229137199434,3.5991699488889406,"['IL1R1', 'IL1B', 'TIMP2', 'CCL2', 'F2', 'ICAM1', 'TLR2']",0.7145318172085519,0,0,7
117,Development of ureteric collection system WP5053,0.14761929897921416,1.525993943538146,2.9194074326873203,"['SMAD1', 'FOXC1', 'SMO', 'ITGA8', 'GFRA1', 'SPRY1', 'GLI1', 'ETV4', 'GLI3', 'PAX2', 'FREM2', 'GLI2']",0.7312813055683169,0,0,12
118,Cell migration and invasion through p75NTR WP4561,0.1477588939333243,1.6592555901500141,3.172784450875938,"['NGFR', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'BDNF', 'MMP2', 'PARD3', 'CDH11']",0.7312813055683169,0,0,9
119,Hedgehog Signaling Pathway Netpath WP47,0.16048343535039725,2.0478748468570354,3.746719219119479,"['SMO', 'SUFU', 'GLI1', 'GLI3', 'GLI2']",0.7845047458514299,0,0,5
120,IL-3 signaling pathway WP286,0.16632657665861497,1.4527422138643449,2.605932025293394,"['CD86', 'LYN', 'JUN', 'SYK', 'YWHAB', 'BAD', 'CSF2RB', 'HCK', 'INPP5D', 'BCL2', 'PTPN6', 'HRAS', 'MAPK3']",0.7845047458514299,0,0,13
121,Proteoglycan biosynthesis WP4784,0.168090076133966,1.8431843891402715,3.286868286208823,"['CSGALNACT1', 'XYLT1', 'B3GALT6', 'CHST14', 'B4GALT7', 'CHST3']",0.7845047458514299,0,0,6
122,Differentiation Pathway WP2848,0.17072423495073616,1.5022499134648668,2.6555357128091845,"['CSF1R', 'CNTF', 'TPO', 'NOTCH1', 'CSF1', 'HGF', 'FST', 'FGF2', 'DKK1', 'NODAL', 'FGF10']",0.7845047458514299,0,0,11
123,Ferroptosis WP4313,0.17072423495073616,1.5022499134648668,2.6555357128091845,"['PRNP', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC3', 'HMOX1', 'VDAC2', 'SAT2', 'SLC7A11', 'CP', 'FTL']",0.7845047458514299,0,0,11
124,Benzo(a)pyrene metabolism WP696,0.17200476317148056,2.764128284826222,4.86551012639468,"['EPHX1', 'CYP1B1', 'CYP3A4']",0.7845047458514299,0,0,3
125,COVID-19 adverse outcome pathway WP4891,0.17200476317148056,2.764128284826222,4.86551012639468,"['IL7', 'IL1B', 'CCL2']",0.7845047458514299,0,0,3
126,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.17200476317148056,2.764128284826222,4.86551012639468,"['CEBPB', 'ALDH1L1', 'ALDH1A1']",0.7845047458514299,0,0,3
127,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.17200476317148056,2.764128284826222,4.86551012639468,"['HEY1', 'VEGFC', 'HES1']",0.7845047458514299,0,0,3
128,Peroxiredoxin 2 induced ovarian failure WP4873,0.17200476317148056,2.764128284826222,4.86551012639468,"['STAR', 'CYP11A1', 'BAX']",0.7845047458514299,0,0,3
129,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.173289575710333,1.6385587624976419,2.872051438200154,"['ABCA1', 'CYP26A1', 'ABCC2', 'NR1I3', 'CYP4A11', 'CYP3A4', 'ABCB11', 'PPARA']",0.7845047458514299,0,0,8
130,Prader-Willi and Angelman Syndrome WP3998,0.18013121570355167,1.3829387581514034,2.370453446552955,"['PCSK1', 'MAGEL2', 'BDNF', 'ATP10A', 'TYR', 'POMC', 'GABRR2', 'GABRR1', 'E2F1', 'NDN', 'MKRN3', 'GHRL', 'MSX1', 'CGA', 'GABRD']",0.8092048459298014,0,0,15
131,Regulation of toll-like receptor signaling pathway WP1449,0.1826195118533336,1.2441132272820554,2.1154284993165335,"['CD86', 'CUEDC2', 'CD80', 'PELI3', 'PELI2', 'LY96', 'PIK3R5', 'TIFA', 'FADD', 'MAPK3', 'JUN', 'TICAM2', 'CISH', 'SYK', 'CD180', 'IRAK3', 'SMAD6', 'NFKB2', 'TOLLIP', 'IL1B', 'IRF7', 'PELI1', 'TLR9', 'TLR7', 'PTPN6', 'TLR6', 'TLR5', 'TLR4', 'TLR2']",0.8133522847806688,0,0,29
132,Pathogenic Escherichia coli infection WP2272,0.18383989998467173,1.3953238953238953,2.3632461407125054,"['ARPC5L', 'LY96', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1C', 'TUBA1A', 'TUBB2A', 'CDH1', 'TUBB3', 'HCLS1', 'TLR5', 'EZR', 'TLR4']",0.8133522847806688,0,0,14
133,Prostaglandin Synthesis and Regulation WP98,0.19112270996420164,1.4273234030887325,2.361991284698391,"['HSD11B1', 'HSD11B2', 'HPGDS', 'EDN1', 'HPGD', 'CYP11A1', 'ANXA3', 'PTGER2', 'TBXAS1', 'S100A6', 'SOX9', 'PTGDR']",0.8244541902163129,0,0,12
134,Genes controlling nephrogenesis WP4823,0.19781811579310543,1.474745186862967,2.389687833355852,"['NOTCH2', 'FOXC1', 'FOXD1', 'EYA1', 'LAMB2', 'ITGA8', 'CXCR4', 'ETV4', 'GLI3', 'PAX2']",0.8244541902163129,0,0,10
135,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.19781811579310543,1.474745186862967,2.389687833355852,"['LDHA', 'EDN1', 'ANGPT2', 'PKM', 'BCL2A1', 'IGFBP2', 'PGK1', 'PMAIP1', 'BAX', 'SLC2A3']",0.8244541902163129,0,0,10
136,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.20066994084090944,1.5081825901242827,2.422282716302979,"['PDGFRA', 'EDA', 'SMO', 'CDH1', 'MYC', 'LEF1', 'LRP5', 'GLI1', 'GLI2']",0.8244541902163129,0,0,9
137,Airway smooth muscle cell contraction WP4962,0.20070919354251174,1.842945999434549,2.9595836942285296,"['RYR1', 'CD38', 'ADRB2', 'CALM1', 'CALM2']",0.8244541902163129,0,0,5
138,Galanin receptor pathway WP4970,0.20070919354251174,1.842945999434549,2.9595836942285296,"['YAP1', 'POMC', 'CDKN1A', 'CDKN1B', 'UCP1']",0.8244541902163129,0,0,5
139,Major receptors targeted by epinephrine and norepinephrine WP4589,0.20070919354251174,1.842945999434549,2.9595836942285296,"['ADCY10', 'ADCY9', 'ADCY4', 'ADRA1D', 'ADRB2']",0.8244541902163129,0,0,5
140,miRNAs involved in DNA damage response WP1545,0.20070919354251174,1.842945999434549,2.9595836942285296,"['CDKN1A', 'CCND3', 'CDKN1B', 'MYC', 'E2F1']",0.8244541902163129,0,0,5
141,Selective expression of chemokine receptors during T-cell polarization WP4494,0.20070919354251174,1.842945999434549,2.9595836942285296,"['CCR1', 'IL4R', 'IL5', 'CXCR4', 'IL18R1']",0.8244541902163129,0,0,5
142,Aflatoxin B1 metabolism WP699,0.20187833767283003,3.6850282485875705,5.896377041085977,"['EPHX1', 'CYP3A4']",0.8244541902163129,0,0,2
143,Vitamin B6-dependent and responsive disorders WP4228,0.20187833767283003,3.6850282485875705,5.896377041085977,"['PNPO', 'AASS']",0.8244541902163129,0,0,2
144,GDNF/RET signaling axis WP4830,0.20385567985686617,1.7012704490080055,2.7056035278798145,"['FOXC1', 'EYA1', 'GFRA1', 'SPRY1', 'PAX2', 'GLI3']",0.8267480349750683,0,0,6
145,Allograft Rejection WP2328,0.21567133665095437,1.3110985063339005,2.011224610066018,"['CD86', 'C1QB', 'PDGFRA', 'C1QA', 'HLA-DRB5', 'CD80', 'CXCR5', 'HLA-E', 'CASP7', 'C6', 'IL5', 'C7', 'IL1B', 'C9', 'VIM', 'C1QC']",0.8581763854842461,0,0,16
146,Fas ligand pathway and stress induction of heat shock proteins WP314,0.21983283802322737,1.398431625308841,2.1184670762949454,"['ACTA1', 'CASP7', 'JUN', 'CASP6', 'CASP10', 'BCL2', 'HSPB1', 'CYCS', 'FADD', 'CFLAR', 'ACTG1']",0.8581763854842461,0,0,11
147,Pyrimidine metabolism WP4022,0.2244338784966234,1.2491181940614378,1.8664001071628733,"['CDA', 'POLR2J2', 'NME2', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLD1', 'DPYD', 'POLE3', 'POLR2E', 'CMPK2', 'POLR3H', 'POLR2I', 'POLE', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.8581763854842461,0,0,21
148,Cardiac Progenitor Differentiation WP2406,0.22481054385723767,1.417915323634463,2.1162347337108445,"['MESP1', 'PDGFRA', 'NOTCH1', 'ACTC1', 'CXCR4', 'PAX6', 'THY1', 'FGF2', 'DKK1', 'NODAL']",0.8581763854842461,0,0,10
149,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.22481054385723767,1.417915323634463,2.1162347337108445,"['CREB3', 'STAR', 'CYP11A1', 'CREB3L1', 'HSD3B1', 'ITPR2', 'CALM3', 'REN', 'CALM1', 'CALM2']",0.8581763854842461,0,0,10
150,Tryptophan metabolism WP465,0.22481054385723767,1.417915323634463,2.1162347337108445,"['CYP2J2', 'TPH1', 'HAAO', 'KYNU', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD']",0.8581763854842461,0,0,10
151,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.23352079031204373,2.211133088443063,3.216058070697769,"['TLR4', 'NFKB2', 'TLR2']",0.8581763854842461,0,0,3
152,Dual hijack model of Vif in HIV infection WP3300,0.23352079031204373,2.211133088443063,3.216058070697769,"['ELOB', 'ELOC', 'RUNX1']",0.8581763854842461,0,0,3
153,HIF1A and PPARG regulation of glycolysis WP2456,0.23352079031204373,2.211133088443063,3.216058070697769,"['LDHA', 'TPI1', 'GAPDH']",0.8581763854842461,0,0,3
154,NAD Biosynthesis II (from tryptophan) WP2485,0.23352079031204373,2.211133088443063,3.216058070697769,"['KYNU', 'HAAO', 'KMO']",0.8581763854842461,0,0,3
155,Ovarian infertility WP34,0.23438058288387467,1.4744765138653084,2.139183888370862,"['EGR1', 'CEBPB', 'CDKN1B', 'PTGER2', 'GJA4', 'PGR', 'BMPR1B', 'PRLR']",0.8581763854842461,0,0,8
156,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.2366312035071424,1.2824977188093418,1.8484029834300348,"['CDKN1A', 'JUN', 'CDKN1B', 'FZD2', 'WNT16', 'ELK1', 'EGFR', 'SOD1', 'ACTA1', 'MYC', 'TMSB4X', 'NEFL', 'PFN4', 'NEFM', 'NEFH', 'PFN2']",0.8581763854842461,0,0,16
157,G1 to S cell cycle control WP45,0.2366312035071424,1.2824977188093418,1.8484029834300348,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'GADD45A', 'MYT1', 'CREB3', 'CCND3', 'TFDP2', 'MYC', 'CREB3L1', 'RPA3', 'CDK2', 'E2F1', 'CDK1', 'MCM4', 'POLE']",0.8581763854842461,0,0,16
158,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.24203660132767651,1.5796299288946347,2.2409677767748732,"['H3F3B', 'BCL6', 'H2AFZ', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.8581763854842461,0,0,6
159,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.2424346897504271,1.8427077444884115,2.611159118926718,"['SMAD1', 'SST', 'DKK1', 'FOXO1']",0.8581763854842461,0,0,4
160,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.2424346897504271,1.8427077444884115,2.611159118926718,"['HLA-DRB5', 'CD8B', 'IGLL1', 'CD247']",0.8581763854842461,0,0,4
161,Sulfation Biotransformation Reaction WP692,0.2424346897504271,1.8427077444884115,2.611159118926718,"['SULT1C2', 'SULT1B1', 'SULT4A1', 'SULT1A2']",0.8581763854842461,0,0,4
162,Dopaminergic Neurogenesis WP2855,0.2438564534878972,1.675276942452515,2.3641098308242214,"['ALDH1A1', 'MSX1', 'GLI1', 'SLC18A2', 'GLI2']",0.8581763854842461,0,0,5
163,Glutathione metabolism WP100,0.2438564534878972,1.675276942452515,2.3641098308242214,"['GGT5', 'GSTM2', 'GPX4', 'GPX3', 'GSTA1']",0.8581763854842461,0,0,5
164,MAPK pathway in congenital thyroid cancer WP4928,0.2438564534878972,1.675276942452515,2.3641098308242214,"['GAREM2', 'JUN', 'MYC', 'ELK1', 'MAPK3']",0.8581763854842461,0,0,5
165,Serotonin and anxiety WP3947,0.2438564534878972,1.675276942452515,2.3641098308242214,"['POMC', 'GABRA1', 'ARC', 'CRH', 'TRPV1']",0.8581763854842461,0,0,5
166,Wnt signaling WP428,0.24393369861367273,1.198599260523322,1.691054335486017,"['TCF7', 'LEF1', 'LRP5', 'CXXC4', 'NKD1', 'FRAT1', 'CCND3', 'FRAT2', 'WIF1', 'MYC', 'GPC4', 'TCF7L2', 'WNT10A', 'JUN', 'TCF7L1', 'FZD2', 'CSNK2A3', 'SERPINF1', 'NFATC3', 'NFATC2', 'NFATC1', 'WNT16', 'DKK1', 'NFATC4', 'SFRP4', 'DAAM2']",0.8581763854842461,0,0,26
167,DNA damage response WP707,0.2509487044369435,1.2536113475177304,1.733126119142405,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'CCND3', 'RAD51', 'CDK5', 'MYC', 'CDK2', 'E2F1', 'CDK1', 'PMAIP1', 'CYCS', 'BAX', 'SFN', 'RAD9A']",0.8775691221028443,0,0,17
168,CAMKK2  Pathway WP4874,0.2601532029919795,1.3822884234361732,1.8612300461978082,"['FIS1', 'MAP1LC3A', 'VCAM1', 'HMOX1', 'NFATC2', 'CALM1', 'CALM2', 'ICAM1', 'MAPK3']",0.904342086591167,0,0,9
169,Metabolic reprogramming in colon cancer WP4290,0.2738583471009636,1.3080092453019796,1.6940607022571847,"['ACLY', 'LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'SUCLG2', 'PDHB', 'SLC1A5', 'ALDOB', 'GAPDH']",0.9368691427908544,0,0,11
170,Osteoblast differentiation WP4787,0.27774108109091333,1.1691847720524986,1.4978028150712965,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'WNT8A', 'LRP5', 'FGF2', 'PIK3R6', 'GLI3', 'PIK3R5', 'GLI2', 'DLL3', 'HEY1', 'HEY2', 'SOX9', 'MAPK3', 'SMAD1', 'WNT10A', 'PRKCH', 'FZD2', 'WNT16', 'SMO', 'PRKD1', 'BMPR1B', 'FGFR4', 'FGFR3', 'FGF10']",0.9368691427908544,0,0,26
171,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.28910818826456186,1.53555272830082,1.9055507719118678,"['CDKN1A', 'ALPL', 'ROS1', 'FGFR3', 'NFKB2']",0.9368691427908544,0,0,5
172,miR-509-3p alteration of YAP1/ECM axis WP3967,0.28910818826456186,1.53555272830082,1.9055507719118678,"['YAP1', 'COL1A1', 'PBX3', 'TEAD2', 'TEAD3']",0.9368691427908544,0,0,5
173,MED and Pseudoachondroplasia genes WP4789,0.2905994327604624,2.456497175141243,3.0357624961604515,"['COL9A1', 'MATN3']",0.9368691427908544,0,0,2
174,miR-517 relationship with ARCN1 and USP1 WP3596,0.2905994327604624,2.456497175141243,3.0357624961604515,"['CDKN1A', 'ARCN1']",0.9368691427908544,0,0,2
175,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.2905994327604624,2.456497175141243,3.0357624961604515,"['MAS1', 'REN']",0.9368691427908544,0,0,2
176,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.2905994327604624,2.456497175141243,3.0357624961604515,"['EGFR', 'MAPK3']",0.9368691427908544,0,0,2
177,Amyotrophic lateral sclerosis (ALS) WP2447,0.2917702864845734,1.326894990093405,1.634453958240686,"['BAD', 'SLC1A2', 'CASP1', 'BCL2', 'NEFL', 'BAX', 'NEFM', 'NEFH', 'SOD1']",0.9368691427908544,0,0,9
178,B Cell Receptor Signaling Pathway WP23,0.2917959942762104,1.1755434782608696,1.447917337856567,"['LYN', 'JUN', 'GSK3A', 'SYK', 'NFATC3', 'GAB1', 'DAPP1', 'NFATC2', 'ELK1', 'FOXO1', 'PTPRC', 'BCL6', 'MYC', 'INPP5D', 'PLCG2', 'BLNK', 'HCLS1', 'PTPN6', 'PIK3AP1', 'HRAS', 'CARD11', 'CD22']",0.9368691427908544,0,0,22
179,miRNA regulation of DNA damage response WP1530,0.2944911148799815,1.2052100381887616,1.4733770411113754,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'CCND3', 'RAD51', 'CDK5', 'MYC', 'CDK2', 'E2F1', 'CDK1', 'PMAIP1', 'CYCS', 'BAX', 'SFN', 'RAD9A']",0.9368691427908544,0,0,17
180,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.295091860615644,1.6378368192952704,1.998928375802292,"['RYR1', 'CD38', 'CCK', 'RYR3']",0.9368691427908544,0,0,4
181,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.2980357689254098,1.8424696241876237,2.2303864395354798,"['CYP4A11', 'PPARA', 'CYP2C18']",0.9368691427908544,0,0,3
182,Estrogen metabolism WP697,0.2980357689254098,1.8424696241876237,2.2303864395354798,"['GSTA1', 'CYP1B1', 'CYP3A4']",0.9368691427908544,0,0,3
183,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.2980357689254098,1.8424696241876237,2.2303864395354798,"['NOTCH1', 'TBX6', 'DLL3']",0.9368691427908544,0,0,3
184,Tgif disruption of Shh signaling WP3674,0.2980357689254098,1.8424696241876237,2.2303864395354798,"['TGIF2', 'NODAL', 'GLI3']",0.9368691427908544,0,0,3
185,Trans-sulfuration pathway WP2333,0.2980357689254098,1.8424696241876237,2.2303864395354798,"['AHCY', 'GOT1', 'MAT2B']",0.9368691427908544,0,0,3
186,Base Excision Repair WP4752,0.30159486103541205,1.3402274013479447,1.6064912932098419,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'POLD1', 'APEX1', 'POLE3', 'POLE']",0.9368691427908544,0,0,8
187,GABA receptor Signaling WP4159,0.30159486103541205,1.3402274013479447,1.6064912932098419,"['GABRA1', 'GABRB1', 'SLC32A1', 'GAD1', 'AP2S1', 'GABRE', 'GABRD', 'AP2M1']",0.9368691427908544,0,0,8
188,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.30159486103541205,1.3402274013479447,1.6064912932098419,"['COL1A1', 'FKBP10', 'ADAMTS2', 'COL1A2', 'P4HA1', 'CREB3L1', 'SERPINF1', 'LRP5']",0.9368691427908544,0,0,8
189,IL-5 signaling pathway WP127,0.31287988843286074,1.270941539422814,1.4767526079590048,"['LYN', 'GSK3A', 'SPRED1', 'JUN', 'SYK', 'MYC', 'BCL2', 'CSF2RB', 'ELK1', 'MAPK3']",0.9667823007660882,0,0,10
190,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.3171020254893979,1.182379231901512,1.3580000409859239,"['DSP', 'TCF7L2', 'TCF7L1', 'ITGB5', 'ITGB4', 'LEF1', 'TCF7', 'ACTG1', 'GJA1', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGA6', 'CTNNA2', 'CACNG1', 'CACNG4', 'CACNG5']",0.9746714888726756,0,0,17
191,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.32342051795621646,1.3819640837104072,1.5599636686874183,"['JUN', 'ABCC2', 'SRXN1', 'EPHX1', 'HMOX1', 'ABCG2']",0.9888878664211017,0,0,6
192,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.33061504670514585,1.1519555650198752,1.274985089002925,"['TCF7L2', 'TCF7L1', 'WNT10A', 'JUN', 'FZD2', 'CSNK2A3', 'SERPINF1', 'TCF7', 'LEF1', 'LRP5', 'WNT16', 'DKK1', 'CXXC4', 'NKD1', 'SFRP4', 'FRAT1', 'CCND3', 'FRAT2', 'WIF1', 'MYC']",0.999983391760135,0,0,20
193,Nicotine Activity on Dopaminergic Neurons WP1602,0.3356536076201918,1.4173245470955396,1.5472585976993158,"['CHRNB2', 'CDK5', 'DRD2', 'DRD3', 'SLC18A2']",0.999983391760135,0,0,5
194,Copper homeostasis WP3286,0.3438955661802371,1.2284824462061155,1.31130335979056,"['PRNP', 'JUN', 'STEAP4', 'SCO2', 'COX17', 'XAF1', 'SOD3', 'FOXO1', 'ATOX1', 'SOD1']",0.999983391760135,0,0,10
195,Nephrotic syndrome WP4758,0.3438955661802371,1.2284824462061155,1.31130335979056,"['CUBN', 'ANLN', 'TRPC6', 'ITGB4', 'LAMB2', 'ARHGDIA', 'GPC5', 'EMP2', 'ARHGAP24', 'PAX2']",0.999983391760135,0,0,10
196,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.34893521958767765,1.4739400791407575,1.5518658042672453,"['CDH1', 'E2F1', 'TULP3', 'PMAIP1']",0.999983391760135,0,0,4
197,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.34893521958767765,1.4739400791407575,1.5518658042672453,"['CDH1', 'MYC', 'ALPL', 'ITGA6']",0.999983391760135,0,0,4
198,Nephrogenesis WP5052,0.34893521958767765,1.4739400791407575,1.5518658042672453,"['NOTCH2', 'FOXD1', 'BMP7', 'PAX2']",0.999983391760135,0,0,4
199,Striated Muscle Contraction Pathway WP383,0.3503266378636521,1.2898019801980198,1.3528595073280947,"['MYOM1', 'ACTA1', 'ACTC1', 'TPM2', 'VIM', 'MYL9', 'ACTG1']",0.999983391760135,0,0,7
200,Senescence and Autophagy in Cancer WP615,0.35148069679141,1.1263020833333333,1.1776620056111629,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'CDKN1B', 'SERPINB2', 'HMGA1', 'CXCL1', 'GABARAP', 'COL1A1', 'MMP14', 'MAP1LC3A', 'IFI16', 'IL1B', 'BCL2', 'IRF7', 'E2F1', 'IGFBP7', 'HRAS', 'CD44', 'SLC39A3']",0.999983391760135,0,0,22
201,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.3611216976733054,1.1923217885284956,1.2144277502033305,"['PDGFRA', 'CDKN1A', 'HSP90AA1', 'JUN', 'MMP2', 'TNFSF10', 'BCL2', 'BAX', 'CFLAR', 'ELK1', 'EGFR']",0.999983391760135,0,0,11
202,Gene regulatory network modelling somitogenesis  WP2854,0.3632783938082213,1.5791385782908811,1.5990133220266647,"['NOTCH1', 'HES1', 'TBX6']",0.999983391760135,0,0,3
203,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.36356938627790214,1.1392082527401677,1.152633954578506,"['TCF7L2', 'CDKN1A', 'TCF7L1', 'JUN', 'GADD45B', 'BAD', 'GADD45A', 'LEF1', 'TCF7', 'TGFBR2', 'MYC', 'BCL2', 'RAC3', 'PMAIP1', 'CYCS', 'BAX', 'MAPK3']",0.999983391760135,0,0,17
204,DNA Mismatch Repair WP531,0.36550105572529257,1.300572265105137,1.3090079216420707,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE3', 'POLE']",0.999983391760135,0,0,6
205,RAS and bradykinin pathways in COVID-19 WP4969,0.36550105572529257,1.300572265105137,1.3090079216420707,"['F12', 'IL1B', 'REN', 'CYP3A4', 'KLKB1', 'PRKG1']",0.999983391760135,0,0,6
206,"Relationship between inflammation, COX-2 and EGFR WP4483",0.36550105572529257,1.300572265105137,1.3090079216420707,"['PTGES2', 'PTGER2', 'HRAS', 'EGFR', 'MAPK3', 'PLA1A']",0.999983391760135,0,0,6
207,Zinc homeostasis WP3529,0.36550105572529257,1.300572265105137,1.3090079216420707,"['SLC30A3', 'SLC30A2', 'SLC39A11', 'SLC39A7', 'SLC39A12', 'SLC39A3']",0.999983391760135,0,0,6
208,Calcium Regulation in the Cardiac Cell WP536,0.37047632343929293,1.0861229287953427,1.078482858412306,"['RYR1', 'CHRM1', 'RGS14', 'YWHAB', 'ADCY4', 'ITPR2', 'ADRA1D', 'ADRB2', 'RYR3', 'RGS4', 'GJA1', 'GNG3', 'PLN', 'GJA4', 'RGS20', 'SFN', 'YWHAG', 'YWHAH', 'PRKCH', 'ATP1B1', 'GNG12', 'GNG11', 'GJD2', 'SLC8A3', 'GJB2', 'ADCY9', 'PRKAR1A', 'RGS10', 'CALM3', 'PRKD1', 'CASQ1', 'CALM1', 'CALM2']",0.999983391760135,0,0,33
209,Alpha 6 Beta 4 signaling pathway WP244,0.3723646052935223,1.2283531409168083,1.2134676909508604,"['LAMB3', 'LAMA1', 'ITGB4', 'LAMB2', 'GAB1', 'ITGA6', 'HRAS', 'MAPK3']",0.999983391760135,0,0,8
210,Melatonin metabolism and effects WP3298,0.3723646052935223,1.2283531409168083,1.2134676909508604,"['PER2', 'EDN1', 'CYP1B1', 'ECE1', 'CYP2C19', 'CALM1', 'CALM2', 'FOXO1']",0.999983391760135,0,0,8
211,FTO Obesity Variant Mechanism WP3407,0.3778279399188079,1.842231638418079,1.7930742154087378,"['PRDM16', 'UCP1']",0.999983391760135,0,0,2
212,Hfe effect on hepcidin production WP3924,0.3778279399188079,1.842231638418079,1.7930742154087378,"['HJV', 'HAMP']",0.999983391760135,0,0,2
213,Arylamine metabolism WP694,0.3814510384272777,3.684269980231573,3.5507991068750324,['SULT1A2'],0.999983391760135,0,0,1
214,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3827242835741151,1.315986106062442,1.2639262685204526,"['CASP7', 'BAD', 'BCL2', 'BAX', 'FADD']",0.999983391760135,0,0,5
215,PPAR-alpha pathway WP2878,0.3827242835741151,1.315986106062442,1.2639262685204526,"['MYC', 'CYP4A11', 'CDK1', 'APOA1', 'PPARA']",0.999983391760135,0,0,5
216,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.3889753125515704,1.2282885431400283,1.1597984385433082,"['GGT5', 'CYSLTR2', 'HPGD', 'TRPA1', 'CYP4A11', 'TRPV1', 'PPARA']",0.999983391760135,0,0,7
217,Cytosolic DNA-sensing pathway WP4655,0.39030673050301307,1.1406509330850505,1.0731499033820622,"['IL33', 'CCL4L2', 'CGAS', 'CASP10', 'IL1B', 'CASP1', 'IRF7', 'POLR2E', 'POLR3H', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.999983391760135,0,0,13
218,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.39077439437737466,1.050848800027922,0.9874036797267095,"['CDKN1A', 'CDKN1B', 'CHRM1', 'FLT1', 'CSF1', 'ITGB5', 'ITGB4', 'SLC2A2', 'SLC2A3', 'HIF3A', 'FGF2', 'GYS2', 'GYS1', 'CREB3L1', 'TNR', 'ITGB8', 'PELO', 'HRAS', 'PDGFRA', 'HSP90AA1', 'IL4R', 'VWF', 'HGF', 'OSMR', 'PRLR', 'CREB3', 'CDC37', 'COL4A6', 'ITGA8', 'ITGA6', 'EPHA2', 'CSF1R', 'PHLPP1', 'EPAS1', 'LAMA1', 'LPAR3', 'EGFR', 'FOXO1', 'THBS4', 'PIK3R5', 'GNG10', 'GNG3', 'PDGFC', 'MAPK3', 'NGFR', 'ANGPT2', 'LAMB3', 'LAMB2', 'BAD', 'VEGFC', 'GNG12', 'GNG11', 'COL1A1', 'FGF17', 'EFNA3', 'COL1A2', 'COL5A3', 'ITGA10', 'FGFR4', 'FGFR3', 'FGF10']",0.999983391760135,0,0,61
219,Bladder cancer WP2828,0.39098788537453993,1.184454732926287,1.1122962145642559,"['CDKN1A', 'RPS6KA5', 'CDH1', 'MYC', 'MMP2', 'E2F1', 'HRAS', 'FGFR3', 'EGFR']",0.999983391760135,0,0,9
220,Neovascularisation processes WP4331,0.39098788537453993,1.184454732926287,1.1122962145642559,"['ACVRL1', 'NOTCH3', 'SMAD1', 'NOTCH1', 'CXCR4', 'EPHB4', 'RELB', 'MAPK3', 'NFKB2']",0.999983391760135,0,0,9
221,Alzheimer's disease WP2059,0.39786825800870285,1.1055902383654939,1.0189499280123577,"['PSENEN', 'ATP5MD', 'BAD', 'ITPR2', 'LPL', 'GRIN2C', 'RYR3', 'CASP7', 'CDK5', 'IL1B', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.999983391760135,0,0,18
222,Fatty acid transporters WP5061,0.40283557603934067,1.339842746287065,1.2182209329676403,"['FABP3', 'FABP6', 'FABP7', 'ACSBG1']",0.999983391760135,0,0,4
223,ID signaling pathway WP53,0.40283557603934067,1.339842746287065,1.2182209329676403,"['CDK2', 'ID3', 'ELK1', 'PAX2']",0.999983391760135,0,0,4
224,Overview of nanoparticle effects WP3287,0.40283557603934067,1.339842746287065,1.2182209329676403,"['CCND3', 'BCL2', 'HMOX1', 'BAX']",0.999983391760135,0,0,4
225,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.40283557603934067,1.339842746287065,1.2182209329676403,"['PTTG1', 'BUB1B', 'ANAPC11', 'MAD2L1']",0.999983391760135,0,0,4
226,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.40518072151248363,1.1338417955981694,1.0243377195474521,"['VAV3', 'BEX3', 'SOCS3', 'CDKN1A', 'CASP7', 'CDKN1B', 'HSPA5', 'HSPB1', 'TNFRSF10B', 'RNF7', 'VIM', 'YBX3']",0.999983391760135,0,0,12
227,NO/cGMP/PKG mediated Neuroprotection WP4008,0.40709816770903856,1.1515253397508494,1.034876887212992,"['BAD', 'IL1B', 'NPPA', 'BCL2', 'PDE3A', 'NEFL', 'CYCS', 'GRIN2C', 'CALM1', 'CALM2']",0.999983391760135,0,0,10
228,Physiological and pathological hypertrophy of the heart WP1528,0.40779355809179674,1.2282239819004526,1.1017098098060885,"['EDN1', 'JUN', 'LIFR', 'CALM1', 'CALM2', 'NFATC4']",0.999983391760135,0,0,6
229,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.40779355809179674,1.2282239819004526,1.1017098098060885,"['GSK3A', 'CD8B', 'NFATC2', 'PTPN6', 'CALM1', 'CALM2']",0.999983391760135,0,0,6
230,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4082722436021315,1.179128466327108,1.056288116553481,"['YAP1', 'FYB1', 'LATS2', 'RAB13', 'LPL', 'FOXO1', 'TEAD2', 'TEAD3']",0.999983391760135,0,0,8
231,Acute viral myocarditis WP4298,0.4110968044509944,1.0990668159761106,0.9769896820406121,"['EDN1', 'ENDOG', 'CD80', 'CXCR4', 'NOD2', 'NFKB2', 'CASP7', 'CASP6', 'CASP1', 'BCL2', 'RAC3', 'CYCS', 'BAX', 'TLR5', 'TLR4', 'EIF4G2', 'MAPK3']",0.999983391760135,0,0,17
232,TNF-alpha signaling pathway WP231,0.41719398899781146,1.0838594381534556,0.9475142171684293,"['HSP90AA1', 'JUN', 'BAD', 'TXN', 'CFLAR', 'TNFRSF1B', 'SELE', 'NFKB2', 'CASP7', 'PSMD2', 'RFK', 'CDC37', 'CCL2', 'BAX', 'FADD', 'NFKBIE', 'HRAS', 'NOX1', 'SKP1', 'MAPK3']",0.999983391760135,0,0,20
233,IL-2 signaling pathway WP49,0.42464146295932204,1.143523624544931,0.9794395141926295,"['SOCS3', 'JUN', 'SYK', 'CISH', 'MYC', 'BCL2', 'NMI', 'HRAS', 'MAPK3']",0.999983391760135,0,0,9
234,Neural Crest Cell Migration during Development WP4564,0.42464146295932204,1.143523624544931,0.9794395141926295,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'MMP2', 'CDH11', 'PIK3R6', 'EPHB4', 'PIK3R5']",0.999983391760135,0,0,9
235,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.4274230828134403,1.3816402938683243,1.174367901958606,"['TPO', 'CSF1', 'IKZF1']",0.999983391760135,0,0,3
236,Osteoblast Signaling WP322,0.4274230828134403,1.3816402938683243,1.174367901958606,"['COL1A1', 'PDGFRA', 'PTH1R']",0.999983391760135,0,0,3
237,Serotonin Transporter Activity WP1455,0.4274230828134403,1.3816402938683243,1.174367901958606,"['IL1R1', 'IL1B', 'TGFB1I1']",0.999983391760135,0,0,3
238,miRNAs involvement in the immune response in sepsis WP4329,0.42766493390652177,1.1723672367236724,0.9958266149874757,"['VCAM1', 'IRF7', 'TLR7', 'TLR4', 'ICAM1', 'RELB', 'NFKB2']",0.999983391760135,0,0,7
239,One-carbon metabolism WP241,0.42962016130233194,1.2281594571670909,1.0376151923555625,"['AHCYL2', 'ALDH1L1', 'AHCY', 'DNMT3A', 'MAT2B']",0.999983391760135,0,0,5
240,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.42962016130233194,1.2281594571670909,1.0376151923555625,"['CD86', 'LDHA', 'CD80', 'MYC', 'SLC2A3']",0.999983391760135,0,0,5
241,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.42962016130233194,1.2281594571670909,1.0376151923555625,"['GSDMD', 'FCGR2A', 'IL1B', 'CGAS', 'NFKBIE']",0.999983391760135,0,0,5
242,Hepatitis B infection WP4666,0.4357232606599457,1.052879921900423,0.8746778476777253,"['CDKN1A', 'YWHAB', 'ELK1', 'CASP10', 'MYC', 'CREB3L1', 'FADD', 'HRAS', 'MAPK3', 'JUN', 'EGR2', 'TICAM2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'BAD', 'NFATC3', 'NFATC2', 'NFATC1', 'HSPG2', 'NFATC4', 'TGFBR2', 'CREB3', 'VDAC3', 'BCL2', 'IRF7', 'CYCS', 'BAX', 'TLR4', 'TLR2']",0.999983391760135,0,0,30
243,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.4388555660884924,1.1165448368166375,0.9195694975574814,"['ACTA1', 'ACTC1', 'ITGB5', 'ITGB4', 'CDH1', 'ITGB8', 'LIMD1', 'TEAD2', 'ACTG1', 'TEAD3']",0.999983391760135,0,0,10
244,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4400186216409524,1.0837405560466318,0.889684055002532,"['HSPA8', 'HSPA5', 'UBE2L6', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1C', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'TUBB3', 'PSMD2', 'CASP1', 'STUB1']",0.999983391760135,0,0,15
245,Notch Signaling Pathway Netpath WP61,0.44543957729724704,1.0886357196218346,0.8803728156467675,"['PSENEN', 'NOTCH2', 'NOTCH3', 'CDKN1A', 'NOTCH1', 'MAML2', 'DLL3', 'HEY1', 'MYC', 'HEY2', 'HES1', 'HES5', 'SKP1']",0.999983391760135,0,0,13
246,TGF-beta Receptor Signaling WP560,0.4514226127293645,1.0953944598804413,0.8712234308942238,"['TGFBR3', 'SMAD1', 'JUN', 'FST', 'LEF1', 'ZNF423', 'SMAD6', 'HRAS', 'RUNX3', 'TGFBR2', 'MAPK3']",0.999983391760135,0,0,11
247,FOXA2 pathway WP5066,0.455828595413571,1.2280949689089882,0.9648386000494191,"['GSTM2', 'ABCC2', 'GSTA1', 'FOXO1']",0.999983391760135,0,0,4
248,NOTCH1 regulation of endothelial cell calcification WP3413,0.455828595413571,1.2280949689089882,0.9648386000494191,"['NOTCH1', 'ALPL', 'FGFR3', 'DLL3']",0.999983391760135,0,0,4
249,Type II diabetes mellitus WP1584,0.455828595413571,1.2280949689089882,0.9648386000494191,"['SURF1', 'KCNJ11', 'SLC2A2', 'PIK3R5']",0.999983391760135,0,0,4
250,Hedgehog Signaling Pathway WP4249,0.45816992325410427,1.1053212567223323,0.862719988924778,"['EVC2', 'SMO', 'SUFU', 'BOC', 'BCL2', 'LRP2', 'GLI1', 'GLI3', 'GLI2']",0.999983391760135,0,0,9
251,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.46015717364885594,1.4736723163841807,1.143845538886943,"['IL1B', 'CASP1']",0.999983391760135,0,0,2
252,Codeine and Morphine Metabolism WP1604,0.46015717364885594,1.4736723163841807,1.143845538886943,"['ABCC2', 'CYP3A4']",0.999983391760135,0,0,2
253,LDLRAD4 and what we know about it WP4904,0.46015717364885594,1.4736723163841807,1.143845538886943,"['NEDD4', 'TGFBR2']",0.999983391760135,0,0,2
254,"Phase I biotransformations, non P450 WP136",0.46015717364885594,1.4736723163841807,1.143845538886943,"['PON3', 'PON2']",0.999983391760135,0,0,2
255,SARS-CoV-2 and COVID-19 Pathway WP4846,0.46015717364885594,1.4736723163841807,1.143845538886943,"['NRP1', 'TLR7']",0.999983391760135,0,0,2
256,The alternative pathway of fetal androgen synthesis WP4524,0.46015717364885594,1.4736723163841807,1.143845538886943,"['STAR', 'CYP11A1']",0.999983391760135,0,0,2
257,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4626930429071208,1.0783666136944656,0.8310878957570098,"['KAT2B', 'TCF7L2', 'CDKN1A', 'CEBPB', 'TCF7L1', 'NOTCH1', 'MSTN', 'LEF1', 'TCF7', 'E2F1', 'HES1', 'HES5']",0.999983391760135,0,0,12
258,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4655466586276321,1.062817604850494,0.8125697111024295,"['YAP1', 'ANGPT2', 'BAD', 'MMP2', 'TIE1', 'FOXO1', 'EGFR', 'CASP7', 'RAD51', 'MYC', 'STMN1', 'BAX', 'HRAS', 'ANGPTL1', 'MAPK3']",0.999983391760135,0,0,15
259,Matrix Metalloproteinases WP129,0.4757263739682226,1.1513111393836584,0.8553233615897349,"['MMP14', 'MMP16', 'MMP2', 'TIMP2', 'MMP19']",0.999983391760135,0,0,5
260,miRNA targets in ECM and membrane receptors WP2911,0.4757263739682226,1.1513111393836584,0.8553233615897349,"['COL1A2', 'ITGB5', 'LAMB2', 'SDC2', 'COL5A3']",0.999983391760135,0,0,5
261,Synaptic Vesicle Pathway WP2267,0.48136023208517675,1.0664863092310215,0.7797501238993411,"['NSF', 'RAB3A', 'SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'SYN3', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1']",0.999983391760135,0,0,11
262,ACE Inhibitor Pathway WP554,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['MAS1', 'ATP6AP2', 'REN']",0.999983391760135,0,0,3
263,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['SMAD1', 'BMPR1B', 'SMAD6']",0.999983391760135,0,0,3
264,Cancer immunotherapy by CTLA4 blockade WP4582,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['CD86', 'CD80', 'PTPN6']",0.999983391760135,0,0,3
265,Genes targeted by miRNAs in adipocytes WP1992,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['GJA1', 'TMSB4X', 'ERG']",0.999983391760135,0,0,3
266,Iron metabolism in placenta WP2007,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['HEPHL1', 'FTH1', 'HAMP']",0.999983391760135,0,0,3
267,LTF danger signal response pathway WP4478,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['IL1B', 'TLR4', 'TLR2']",0.999983391760135,0,0,3
268,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['MYC', 'PGR', 'VIM']",0.999983391760135,0,0,3
269,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['JUN', 'RYR3', 'MAPK3']",0.999983391760135,0,0,3
270,Purine metabolism WP4792,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['PRPS1', 'XDH', 'APRT']",0.999983391760135,0,0,3
271,RalA downstream regulated genes WP2290,0.4890858508487621,1.2280305170952246,0.8783085980660241,"['RAC3', 'YBX3', 'HRAS']",0.999983391760135,0,0,3
272,7-oxo-C and 7beta-HC pathways WP5064,0.4911228313895847,1.1052319004524886,0.7858873188371239,"['HSD11B1', 'HSD11B2', 'ACOT11', 'THEM5', 'ACOT6', 'ACOT4']",0.999983391760135,0,0,6
273,Mesodermal commitment pathway WP2857,0.4955996485482972,1.0213403810500572,0.7169675049942408,"['YAP1', 'FOXC1', 'LEF1', 'ZIC2', 'ZIC3', 'RPL38', 'TEAD2', 'VAV3', 'SMAD1', 'TCF7L1', 'SLC2A12', 'PBX3', 'PAX6', 'ZIC5', 'TBX6', 'ELP4', 'SMAD6', 'KLF4', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'TBX3', 'ARL4A', 'PRKAR1A', 'BHLHE40', 'RGS10', 'NODAL']",0.999983391760135,0,0,28
274,22q11.2 copy number variation syndrome WP4657,0.49708101954352757,1.0259493670886075,0.7171409149357448,"['RANBP1', 'FOXC1', 'VWF', 'SERPIND1', 'GP1BA', 'RTN4', 'EGFR', 'SLC7A4', 'CLDN5', 'CYP26A1', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'BCL2', 'RCC1', 'DGCR6L', 'HES1', 'DRD2', 'PRODH', 'RAN', 'FGF10']",0.999983391760135,0,0,22
275,miRNA regulation of prostate cancer signaling pathways WP3981,0.5037567327690753,1.0745049504950495,0.7367469990156507,"['CDKN1A', 'CDKN1B', 'BAD', 'CREB3L1', 'TCF7', 'BCL2', 'FOXO1']",0.999983391760135,0,0,7
276,Prion disease pathway WP3995,0.5037567327690753,1.0745049504950495,0.7367469990156507,"['PRNP', 'HSPA5', 'EBF1', 'BCL2', 'ELK1', 'MAPK3', 'BATF']",0.999983391760135,0,0,7
277,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5071271566999548,1.1335391572813844,0.7696657250797926,"['EIF1AX', 'EIF3I', 'EIF3CL', 'EIF1']",0.999983391760135,0,0,4
278,Nicotine Metabolism WP1600,0.5135362284269539,1.8419937870658005,1.2275685771631488,['CYP2A6'],0.999983391760135,0,0,1
279,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5205221912615801,1.0835038001629829,0.7074442887773685,"['H3F3B', 'SUV39H1', 'LEF1', 'E2F1', 'HIST1H3E']",0.999983391760135,0,0,5
280,Statin inhibition of cholesterol production WP430,0.5205221912615801,1.0835038001629829,0.7074442887773685,"['ABCA1', 'LCAT', 'LPL', 'APOA1', 'ACSS1']",0.999983391760135,0,0,5
281,Neural Crest Cell Migration in Cancer WP4565,0.5239634255232779,1.036079465043872,0.6696527588742831,"['NGFR', 'ARF1', 'JUN', 'BDNF', 'MMP2', 'CDH11', 'PIK3R6', 'EPHB4', 'PIK3R5']",0.999983391760135,0,0,9
282,Small cell lung cancer WP4658,0.5265034174508,1.0092335456971055,0.6474207526240425,"['CDKN1A', 'CDKN1B', 'LAMB3', 'GADD45B', 'LAMA1', 'LAMB2', 'GADD45A', 'LAMB4', 'FHIT', 'CKS1B', 'MYC', 'CDK2', 'COL4A6', 'E2F1', 'BCL2', 'CYCS', 'BAX', 'ITGA6', 'RXRG', 'SKP1']",0.999983391760135,0,0,20
283,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5313502946672816,1.0525210084033614,0.6655445947199068,"['TGFBR3', 'HGF', 'HRAS', 'EGFR', 'PIK3R5', 'TGFBR2']",0.999983391760135,0,0,6
284,Melanoma WP4685,0.534215682804854,1.011204481792717,0.6339803340265228,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'ELK1', 'PREX2', 'CDH1', 'E2F1', 'BAX', 'CALM3', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.999983391760135,0,0,14
285,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5357025894717302,1.2279661016949153,0.7664671442279588,"['ELOB', 'ELOC']",0.999983391760135,0,0,2
286,Focal Adhesion WP306,0.5390598547999313,0.9954929229629401,0.6151436142694587,"['FLT1', 'ITGB5', 'ITGB4', 'LAMA1', 'ELK1', 'EGFR', 'THBS4', 'MYL12B', 'ACTG1', 'CCND3', 'PDGFC', 'RAC3', 'TNR', 'ITGB8', 'HRAS', 'MAPK3', 'VAV3', 'PDGFRA', 'JUN', 'CAV3', 'VWF', 'LAMB3', 'LAMB2', 'BAD', 'HGF', 'VEGFC', 'COL1A1', 'MYLPF', 'FGR', 'HCK', 'COL1A2', 'PARVG', 'COL5A3', 'ITGA10', 'COL4A6', 'BCL2', 'ITGA8', 'ITGA6', 'MYL9', 'DOCK1']",0.999983391760135,0,0,40
287,Cysteine and methionine catabolism WP4504,0.5472840131734988,1.105142695676745,0.666166082886538,"['AHCY', 'GOT1', 'SQOR']",0.999983391760135,0,0,3
288,Homologous recombination WP186,0.5472840131734988,1.105142695676745,0.666166082886538,"['POLD4', 'RAD51', 'POLD1']",0.999983391760135,0,0,3
289,Vitamin D-sensitive calcium signaling in depression WP4698,0.5486093490490647,1.0161778194094804,0.6100813147180643,"['TPH1', 'CHRM1', 'CALB1', 'GPX4', 'BCL2', 'ITPR2', 'GRIN2C', 'PVALB']",0.999983391760135,0,0,8
290,Apoptosis Modulation by HSP70 WP384,0.5561195702119284,1.0524913187434386,0.6175723871560591,"['CASP7', 'CASP6', 'CYCS', 'FADD']",0.999983391760135,0,0,4
291,Methionine De Novo and Salvage Pathway WP3580,0.5561195702119284,1.0524913187434386,0.6175723871560591,"['AHCY', 'ODC1', 'TXN', 'MAT2B']",0.999983391760135,0,0,4
292,Nucleotide metabolism WP404,0.5561195702119284,1.0524913187434386,0.6175723871560591,"['PRPS1', 'POLD1', 'NME2', 'OAZ1']",0.999983391760135,0,0,4
293,Transcription co-factors SKI and SKIL protein partners WP4533,0.5561195702119284,1.0524913187434386,0.6175723871560591,"['LATS2', 'MERTK', 'TEAD2', 'TEAD3']",0.999983391760135,0,0,4
294,Androgen receptor signaling pathway WP138,0.5585685737365392,0.9895471563860606,0.5762903810618277,"['CDKN1A', 'JUN', 'TGFB1I1', 'LIMK2', 'DSTN', 'RNF6', 'PARK7', 'ETV5', 'FOXO1', 'EGFR', 'KAT2B', 'SUMO1', 'KAT5', 'BAG1', 'STUB1', 'FKBP4', 'RAN', 'RAD9A']",0.999983391760135,0,0,18
295,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5585685737365392,0.9895471563860606,0.5762903810618277,"['NOTCH1', 'BAD', 'UCP1', 'DIO3', 'ITPR2', 'TRH', 'FOXO1', 'MC4R', 'SLCO1C1', 'POMC', 'CREB3', 'TPO', 'NHSL1', 'TG', 'NPPA', 'ZNF516', 'PRDM16', 'HRAS']",0.999983391760135,0,0,18
296,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5595764179266131,0.9916819291819292,0.575745912578751,"['CDKN1A', 'CDKN1B', 'CR1', 'TRPC6', 'KIRREL2', 'NOTCH1', 'ITGB4', 'LAMB2', 'CD80', 'LRP5', 'DKK1', 'PAX2', 'VIM', 'TLR4']",0.999983391760135,0,0,14
297,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5635835923918185,1.0232306097446047,0.5867609633597635,"['BDNF', 'CGA', 'SGK1', 'FOXO1', 'MAPK3']",0.999983391760135,0,0,5
298,IL-7 signaling pathway WP205,0.5635835923918185,1.0232306097446047,0.5867609633597635,"['CDKN1B', 'BAD', 'IL7', 'MYC', 'MAPK3']",0.999983391760135,0,0,5
299,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5635835923918185,1.0232306097446047,0.5867609633597635,"['GOT1', 'MDH2', 'SCO2', 'IL1B', 'HMGA1']",0.999983391760135,0,0,5
300,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.56848356768075,0.9882227794240559,0.5581312984563879,"['TGFBR3', 'SMAD1', 'JUN', 'FST', 'LEF1', 'ZNF423', 'SMAD6', 'HRAS', 'RUNX3', 'TGFBR2', 'MAPK3']",0.999983391760135,0,0,11
301,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5701798124689043,1.0046020156314275,0.564388935951951,"['CEBPB', 'GJB2', 'MYC', 'PGR', 'PRLR', 'EGFR']",0.999983391760135,0,0,6
302,Oxidative Stress WP408,0.5701798124689043,1.0046020156314275,0.564388935951951,"['GPX3', 'HMOX1', 'XDH', 'SOD3', 'NOX1', 'SOD1']",0.999983391760135,0,0,6
303,Toll-like Receptor Signaling Pathway WP75,0.5757082607275338,0.9783289007092199,0.5401884490650635,"['CD86', 'JUN', 'TICAM2', 'CD80', 'LY96', 'PIK3R5', 'TOLLIP', 'IL1B', 'IRF7', 'TLR9', 'TLR7', 'FADD', 'TLR6', 'TLR5', 'TLR4', 'TLR2', 'MAPK3']",0.999983391760135,0,0,17
304,Disruption of postsynaptic signaling by CNV WP4875,0.5761587910862743,0.9916984006092917,0.5467947080385982,"['TJP1', 'ARC', 'HOMER1', 'GRIN2C', 'YWHAG', 'MAPK3', 'SHANK1']",0.999983391760135,0,0,7
305,The influence of laminopathies on Wnt signaling WP4844,0.5761587910862743,0.9916984006092917,0.5467947080385982,"['TCF7L2', 'CEBPB', 'TCF7L1', 'LEF1', 'TCF7', 'HES1', 'HES5']",0.999983391760135,0,0,7
306,Type 2 papillary renal cell carcinoma WP4241,0.5761587910862743,0.9916984006092917,0.5467947080385982,"['CDKN1A', 'EGLN3', 'EPAS1', 'TFEB', 'COL21A1', 'ELOB', 'ELOC']",0.999983391760135,0,0,7
307,Endoderm differentiation WP2853,0.5771354505008185,0.9770901534675304,0.5370852451787027,"['NOTCH1', 'TCF7', 'ONECUT1', 'LEF1', 'WNT8A', 'FOXO1', 'GLI2', 'ZIC3', 'TCEAL2', 'VAV3', 'DUSP4', 'DUSP5', 'DUSP2', 'TCF7L1', 'SLC2A12', 'PBX3', 'ZIC5', 'ELP4', 'DKK1', 'ZFHX4', 'BMP7', 'GRHL2', 'NME1', 'DAB2', 'RGS10', 'NODAL']",0.999983391760135,0,0,26
308,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5794215363388575,0.9771745479149438,0.5332686038741339,"['IFI27L2', 'JUN', 'PRKCH', 'NOD2', 'RELB', 'NFKB2', 'PLCG2', 'CCL2', 'HRAS', 'TLR4', 'RXRG', 'TLR2', 'MAPK3']",0.999983391760135,0,0,13
309,Integrated Cancer Pathway WP1971,0.5868010775662353,0.9749837665040542,0.519734007882541,"['CDKN1A', 'CDKN1B', 'BAD', 'MYC', 'CDK2', 'E2F1', 'BCL2', 'CDK1', 'BAX']",0.999983391760135,0,0,9
310,DNA damage response (only ATM dependent) WP710,0.5979500552443866,0.9645089285714286,0.495996833967805,"['TCF7L2', 'WNT10A', 'JUN', 'CDKN1A', 'TCF7L1', 'CDKN1B', 'MLKL', 'BAD', 'TCF7', 'LEF1', 'WNT16', 'PIK3R5', 'NFKB2', 'FRAT1', 'CCND3', 'BCL6', 'MYC', 'BCL2', 'PMAIP1', 'RAC3', 'BAX', 'HRAS']",0.999983391760135,0,0,22
311,Corticotropin-releasing hormone signaling pathway WP2355,0.5979647240154877,0.963203491543917,0.49530188673112147,"['HSP90AA1', 'HSD3B1', 'ECE1', 'ELK1', 'TBX19', 'POMC', 'CRHBP', 'NR4A1', 'GJA1', 'STAR', 'CYP11A1', 'CRH', 'PLCG2', 'BCL2', 'TLR4', 'RAPGEF3', 'MAPK3']",0.999983391760135,0,0,17
312,Phytochemical activity on NRF2 transcriptional activation WP3,0.601379099889464,1.0045981145161704,0.5108680395382226,"['CEBPB', 'HMOX1', 'SLC7A11']",0.999983391760135,0,0,3
313,Small Ligand GPCRs WP247,0.601379099889464,1.0045981145161704,0.5108680395382226,"['PTGER2', 'S1PR1', 'PTGDR']",0.999983391760135,0,0,3
314,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.602358281218278,0.9822498586772188,0.49790526179299577,"['EGR1', 'RPS6KA5', 'ELK1', 'MAPK3']",0.999983391760135,0,0,4
315,FOXP3 in COVID-19 WP5063,0.6036073442531403,1.0524616626311543,0.5313156785371838,"['CD86', 'CD80']",0.999983391760135,0,0,2
316,Leptin and adiponectin WP3934,0.6036073442531403,1.0524616626311543,0.5313156785371838,"['LEP', 'LEPR']",0.999983391760135,0,0,2
317,Macrophage markers WP4146,0.6036073442531403,1.0524616626311543,0.5313156785371838,"['CD86', 'CD163']",0.999983391760135,0,0,2
318,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.6036073442531403,1.0524616626311543,0.5313156785371838,"['AHCY', 'MAT2B']",0.999983391760135,0,0,2
319,Thiamine metabolic pathways WP4297,0.6036073442531403,1.0524616626311543,0.5313156785371838,"['BCKDK', 'SLC19A3']",0.999983391760135,0,0,2
320,Vitamin B12 Disorders WP4271,0.6036073442531403,1.0524616626311543,0.5313156785371838,"['CUBN', 'TCN1']",0.999983391760135,0,0,2
321,Angiogenesis WP1539,0.6045809420590142,0.9693019656860556,0.4877718625109993,"['SMAD1', 'PDGFRA', 'FLT1', 'TIMP2', 'FGF2']",0.999983391760135,0,0,5
322,AGE/RAGE pathway WP2324,0.6046775464204557,0.957557381694531,0.4817087629647066,"['JUN', 'NCF1', 'MMP2', 'MSN', 'FOXO1', 'EGFR', 'SOD1', 'LGALS3', 'MMP14', 'ALPL', 'CYCS', 'EZR', 'MAPK3']",0.999983391760135,0,0,13
323,SARS-CoV-2 mitochondrial interactions WP5038,0.6073575821329216,0.9608498917961834,0.47911584937079493,"['IRF7', 'CGAS', 'TLR7', 'PHB', 'NOX1', 'NFKB2']",0.999983391760135,0,0,6
324,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6073575821329216,0.9608498917961834,0.47911584937079493,"['IRF7', 'TLR9', 'TLR7', 'TLR6', 'TLR4', 'TLR2']",0.999983391760135,0,0,6
325,Parkinson's disease pathway WP2371,0.6103913104680818,0.9548954895489549,0.4713889662311368,"['CASP7', 'PINK1', 'CASP6', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.999983391760135,0,0,7
326,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6103913104680818,0.9548954895489549,0.4713889662311368,"['JUN', 'HGF', 'GAB1', 'ELK1', 'HRAS', 'DOCK1', 'MAPK3']",0.999983391760135,0,0,7
327,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6135377374291517,0.9504719133943078,0.4643183658362499,"['CASP7', 'JUN', 'TNFRSF12A', 'CCL2', 'FADD', 'RELB', 'MAPK3', 'NFKB2']",0.999983391760135,0,0,8
328,Notch Signaling WP268,0.6167209984425344,0.9470543043144232,0.4577478522074815,"['NOTCH2', 'NOTCH3', 'KAT2B', 'NOTCH1', 'DTX3L', 'MFNG', 'HES1', 'HES5', 'DLL3']",0.999983391760135,0,0,9
329,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.6174221012940064,1.2279017226772098,0.5920971210333736,['FMO2'],0.999983391760135,0,0,1
330,GABA metabolism (aka GHB) WP4157,0.6174221012940064,1.2279017226772098,0.5920971210333736,['PON3'],0.999983391760135,0,0,1
331,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.6174221012940064,1.2279017226772098,0.5920971210333736,['CHRM1'],0.999983391760135,0,0,1
332,Sulindac Metabolic Pathway WP2542,0.6174221012940064,1.2279017226772098,0.5920971210333736,['CYP1B1'],0.999983391760135,0,0,1
333,Modulators of TCR signaling and T cell activation WP5072,0.6230488122830142,0.9421140331811925,0.44574280150838136,"['FIBP', 'CDKN1B', 'NDUFB10', 'CD5', 'RHOH', 'ELOB', 'PTPN6', 'RNF7', 'CD247', 'CARD11', 'ZFP36L1']",0.999983391760135,0,0,11
334,Oncostatin M Signaling Pathway WP2374,0.6261562019120283,0.9402688204448195,0.44019194002254547,"['SOCS3', 'EGR1', 'CASP7', 'CEBPB', 'CDKN1B', 'PRKCH', 'CDK2', 'CCL2', 'LIFR', 'OSMR', 'HRAS', 'MAPK3']",0.999983391760135,0,0,12
335,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6292139246994469,0.9387095161102128,0.4348890780991648,"['EGR1', 'JUN', 'CDKN1B', 'KCNIP3', 'MYL12B', 'CCND3', 'MYC', 'APEX1', 'CDK2', 'E2F1', 'CGA', 'HRAS', 'MAPK3']",0.999983391760135,0,0,13
336,7q11.23 copy number variation syndrome WP4932,0.629736366611505,0.9441750753505438,0.4366375524512681,"['ATP5PB', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'ACACB', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'CLDN5', 'ATP5F1B', 'MYC', 'CFL1', 'BCL7B', 'EIF4H', 'ATP5PO', 'GTF2IRD1', 'GAPDH', 'PRKG1', 'MAPK3']",0.999983391760135,0,0,20
337,Leptin signaling pathway WP2034,0.6351669994155138,0.9362160187992868,0.4249178586328439,"['GSK3A', 'CISH', 'BAD', 'ELK1', 'ACACB', 'FOXO1', 'SOCS3', 'CFL2', 'IL1B', 'LEP', 'LEPR', 'PLCG2', 'BAX', 'HRAS', 'MAPK3']",0.999983391760135,0,0,15
338,Retinoblastoma gene in cancer WP2446,0.6408987118854035,0.9343071874669208,0.4156581789481724,"['CDT1', 'CDKN1A', 'CDKN1B', 'H2AFZ', 'SUV39H1', 'TTK', 'ANLN', 'CCND3', 'TFDP2', 'MYC', 'RPA3', 'STMN1', 'CDK2', 'E2F1', 'CDK1', 'MCM4', 'POLE']",0.999983391760135,0,0,17
339,Endothelin Pathways WP2197,0.6426884333704311,0.920743778280543,0.407056426630221,"['ADCY10', 'EDN1', 'RIIAD1', 'ECE1', 'CALM1', 'CALM2']",0.999983391760135,0,0,6
340,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6430833117304734,0.9207213578500707,0.40648098201480415,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'DDIT3', 'BCL2', 'MAPK3']",0.999983391760135,0,0,7
341,Photodynamic therapy-induced unfolded protein response WP3613,0.64327313015183,0.9207661860333616,0.4062290310405408,"['NARS', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9']",0.999983391760135,0,0,5
342,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.64327313015183,0.9207661860333616,0.4062290310405408,"['WIF1', 'MYC', 'LEF1', 'LRP5', 'DKK1']",0.999983391760135,0,0,5
343,ATM Signaling Pathway WP2516,0.6440855660196192,0.9206989247311828,0.405037273146987,"['CDKN1A', 'JUN', 'RAD51', 'CRADD', 'GADD45A', 'CDK2', 'CDK1', 'RAD9A']",0.999983391760135,0,0,8
344,Glycogen Synthesis and Degradation WP500,0.6440855660196192,0.9206989247311828,0.405037273146987,"['GYS2', 'GYS1', 'GSK3A', 'HKDC1', 'PYGM', 'CALM3', 'CALM1', 'CALM2']",0.999983391760135,0,0,8
345,IL-4 signaling pathway WP395,0.6471379851065691,0.920654020385051,0.40066470595609605,"['SOCS3', 'CEBPB', 'HRH1', 'IL4R', 'NFIL3', 'BAD', 'INPP5D', 'PTPN6', 'ELK1', 'MAPK3']",0.999983391760135,0,0,10
346,PPAR signaling pathway WP3942,0.6489721552772701,0.920631549136222,0.3980492898978344,"['FABP3', 'FABP6', 'FABP7', 'CYP4A11', 'UCP1', 'APOA1', 'LPL', 'ACSBG1', 'ANGPTL4', 'PPARA', 'RXRG']",0.999983391760135,0,0,11
347,Biomarkers for pyrimidine metabolism disorders WP4584,0.6510149387572716,0.9208109635490251,0.3952329584217986,"['NT5C', 'DPYD', 'CKB']",0.999983391760135,0,0,3
348,Cholesterol Biosynthesis Pathway WP197,0.6510149387572716,0.9208109635490251,0.3952329584217986,"['IDI1', 'HMGCS1', 'MSMO1']",0.999983391760135,0,0,3
349,Leptin Insulin Overlap WP3935,0.6510149387572716,0.9208109635490251,0.3952329584217986,"['SOCS3', 'LEP', 'LEPR']",0.999983391760135,0,0,3
350,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.6510149387572716,0.9208109635490251,0.3952329584217986,"['ABCA1', 'HMGCS1', 'PPARA']",0.999983391760135,0,0,3
351,Tryptophan catabolism leading to NAD+ production WP4210,0.6510149387572716,0.9208109635490251,0.3952329584217986,"['HAAO', 'KYNU', 'KMO']",0.999983391760135,0,0,3
352,Dopamine metabolism WP2436,0.6636895265834023,0.9208333333333333,0.377487171107453,"['TYR', 'SOD1']",0.999983391760135,0,0,2
353,Nanoparticle triggered regulated necrosis WP2513,0.6636895265834023,0.9208333333333333,0.377487171107453,"['FADD', 'FTL']",0.999983391760135,0,0,2
354,Neuroinflammation WP4919,0.6636895265834023,0.9208333333333333,0.377487171107453,"['JUN', 'TLR4']",0.999983391760135,0,0,2
355,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.6636895265834023,0.9208333333333333,0.377487171107453,"['KLF4', 'ELK1']",0.999983391760135,0,0,2
356,DNA Replication WP466,0.6732060619993544,0.8927303596233986,0.3532568063496613,"['POLD4', 'CDT1', 'POLD1', 'RPA3', 'CDK2', 'MCM4', 'POLE', 'UBA52']",0.999983391760135,0,0,8
357,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6760320135987942,0.8838461538461538,0.3460388913992632,"['TICAM2', 'SYK', 'LY96', 'CCL2', 'PLG', 'TLR4']",0.999983391760135,0,0,6
358,Tumor suppressor activity of SMARCB1 WP4204,0.6760320135987942,0.8838461538461538,0.3460388913992632,"['H3F3B', 'SMO', 'DPF3', 'GLI1', 'GLI3', 'GLI2']",0.999983391760135,0,0,6
359,Cannabinoid receptor signaling WP3869,0.6794993601496934,0.876852861585686,0.33881505749992563,"['ADORA2A', 'PRKAR1A', 'CYP2C19', 'CYP3A4', 'MAPK3']",0.999983391760135,0,0,5
360,Ethanol effects on histone modifications WP3996,0.6794993601496934,0.876852861585686,0.33881505749992563,"['KAT2B', 'ALDH1A3', 'AHCY', 'ADH1B', 'ALDH1A1']",0.999983391760135,0,0,5
361,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6794993601496934,0.876852861585686,0.33881505749992563,"['CDKN1A', 'PTH1R', 'SOX9', 'FGFR3', 'MAPK3']",0.999983391760135,0,0,5
362,Gastric Cancer Network 2 WP2363,0.6794993601496934,0.876852861585686,0.33881505749992563,"['PLAC8', 'MYC', 'S100A6', 'COL9A1', 'EGFR']",0.999983391760135,0,0,5
363,Urea cycle and metabolism of amino groups WP497,0.6854995401246197,0.8665580420975626,0.32721877328243093,"['CKM', 'ODC1', 'PYCR3', 'CKB']",0.999983391760135,0,0,4
364,Hypertrophy Model WP516,0.6960578962692262,0.8499141434999022,0.3079429644041852,"['NR4A3', 'MSTN', 'IL1R1']",0.999983391760135,0,0,3
365,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.6960578962692262,0.8499141434999022,0.3079429644041852,"['SFRP4', 'LEF1', 'DKK3']",0.999983391760135,0,0,3
366,Benzene metabolism WP3891,0.6991276792667349,0.9208556904829144,0.3295944124086774,['EPHX1'],0.999983391760135,0,0,1
367,EV release from cardiac cells and their functional effects WP3297,0.6991276792667349,0.9208556904829144,0.3295944124086774,['KLF2'],0.999983391760135,0,0,1
368,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.6991276792667349,0.9208556904829144,0.3295944124086774,['NRP1'],0.999983391760135,0,0,1
369,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.6991276792667349,0.9208556904829144,0.3295944124086774,['FOXO1'],0.999983391760135,0,0,1
370,Steroid Biosynthesis WP496,0.6991276792667349,0.9208556904829144,0.3295944124086774,['HSD3B1'],0.999983391760135,0,0,1
371,Eukaryotic Transcription Initiation WP405,0.700822581591894,0.8664070042278371,0.30800813818487227,"['TAF13', 'POLR2E', 'TAF7', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.999983391760135,0,0,8
372,Hepatitis C and Hepatocellular Carcinoma WP3646,0.700822581591894,0.8664070042278371,0.30800813818487227,"['CDKN1A', 'CASP7', 'JUN', 'MYC', 'MYOF', 'LEF1', 'CD44', 'MAPK3']",0.999983391760135,0,0,8
373,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7033979316537565,0.8592079207920792,0.3022972703147957,"['NGFR', 'GABRA1', 'GABRB1', 'SLC12A5', 'BDNF', 'GABRE', 'GABRD']",0.999983391760135,0,0,7
374,Gastrin signaling pathway WP4659,0.7051566649978924,0.89886263812474,0.3140044322713942,"['EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'CDKN1B', 'SERPINB2', 'BAD', 'KLF4', 'ELK1', 'RHOD', 'FOXO1', 'EGFR', 'TJP1', 'KAT5', 'CDH1', 'MYC', 'PRKD2', 'PRKD1', 'HRAS', 'CD44', 'MAPK3']",0.999983391760135,0,0,21
375,BDNF-TrkB Signaling WP3676,0.7072978698646781,0.84978680821441,0.29428404956250004,"['ARC', 'TRPC6', 'HOMER1', 'BDNF', 'GAB1', 'HRAS']",0.999983391760135,0,0,6
376,Lipid Metabolism Pathway WP3965,0.7131695691091811,0.8369316575423446,0.28291308168387186,"['ACLY', 'PRKAR1A', 'HILPDA', 'PRKAG2', 'ACSBG1']",0.999983391760135,0,0,5
377,Alanine and aspartate metabolism WP106,0.7161931223815814,0.8184557438794727,0.2732049669332691,"['GOT1', 'GAD1']",0.999983391760135,0,0,2
378,Biogenic Amine Synthesis WP550,0.7161931223815814,0.8184557438794727,0.2732049669332691,"['TPH1', 'GAD1']",0.999983391760135,0,0,2
379,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.7161931223815814,0.8184557438794727,0.2732049669332691,"['IDI1', 'HMGCS1']",0.999983391760135,0,0,2
380,"NAD metabolism, sirtuins and aging WP3630",0.7161931223815814,0.8184557438794727,0.2732049669332691,"['ROS1', 'FOXO1']",0.999983391760135,0,0,2
381,Pathways in clear cell renal cell carcinoma WP4018,0.7188927941373577,0.8790985514853413,0.29014035531384724,"['PDGFRA', 'FLT1', 'TPI1', 'ENO2', 'ACACB', 'EGFR', 'LDHC', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'PFKM']",0.999983391760135,0,0,16
382,1q21.1 copy number variation syndrome WP4905,0.7221611345618736,0.8183531185227059,0.26637965785206175,"['TJP1', 'GJA1', 'PRKAG2', 'TJP2']",0.999983391760135,0,0,4
383,"GPCRs, Class B Secretin-like WP334",0.7221611345618736,0.8183531185227059,0.26637965785206175,"['ADGRE1', 'ADGRE2', 'ADGRG2', 'PTH1R']",0.999983391760135,0,0,4
384,Cell cycle WP179,0.723642298669382,0.8910904712762298,0.2882304051900712,"['CDKN2D', 'ANAPC13', 'CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'YWHAB', 'TTK', 'CDC14A', 'ANAPC11', 'CCND3', 'PTTG1', 'TFDP2', 'PTTG2', 'MYC', 'CDK2', 'CDK1', 'E2F1', 'MCM4', 'SFN', 'YWHAG', 'SKP1', 'YWHAH']",0.999983391760135,0,0,23
385,15q13.3 copy number variation syndrome WP4942,0.7365430079509294,0.789145440600654,0.2413109295835112,"['KAT2B', 'OTUD7A', 'CHRFAM7A']",0.999983391760135,0,0,3
386,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.7365430079509294,0.789145440600654,0.2413109295835112,"['TJP1', 'JUN', 'MAPK3']",0.999983391760135,0,0,3
387,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.7365430079509294,0.789145440600654,0.2413109295835112,"['CDH1', 'VIM', 'MAPK3']",0.999983391760135,0,0,3
388,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7391194824025642,0.8545672590373639,0.2583319991440548,"['PDGFRA', 'DUSP2', 'LIFR', 'CSF2RB', 'OSMR', 'CSF2RA', 'MAPK15', 'EGFR', 'SOCS3', 'PTPRC', 'STMN1', 'IL21R', 'MAPK3']",0.999983391760135,0,0,13
389,IL17 signaling pathway WP2112,0.7442542642935863,0.8004818625462502,0.23644036852921146,"['CEBPB', 'IL17RE', 'IL17RD', 'IL17RB', 'MAPK3']",0.999983391760135,0,0,5
390,Signal transduction through IL1R WP4496,0.7442542642935863,0.8004818625462502,0.23644036852921146,"['JUN', 'IL1R1', 'TOLLIP', 'IL1B', 'IRAK3']",0.999983391760135,0,0,5
391,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7474194405603095,0.8283540900084914,0.24115769190047456,"['CD160', 'CXCL17', 'IRF7', 'CCL2', 'CXCL1', 'TLR7', 'FADD', 'CXCL2', 'CXCL5']",0.999983391760135,0,0,9
392,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7474194405603095,0.8283540900084914,0.24115769190047456,"['JUN', 'IL5', 'PTPRC', 'NFATC2', 'PTPN6', 'CALM1', 'CALM2', 'CARD11', 'MAPK3']",0.999983391760135,0,0,9
393,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7555458401461705,0.775222397429413,0.2173063297931016,"['TGFBR3', 'ANGPT2', 'MAPK3', 'TGFBR2']",0.999983391760135,0,0,4
394,Trans-sulfuration and one-carbon metabolism WP2525,0.7555458401461705,0.775222397429413,0.2173063297931016,"['AHCYL2', 'AHCY', 'DNMT3A', 'MAT2B']",0.999983391760135,0,0,4
395,Biomarkers for urea cycle disorders WP4583,0.7616145162145168,0.7365536723163841,0.20057441848122914,"['F7', 'GOT1']",0.999983391760135,0,0,2
396,Serotonin and anxiety-related events WP3944,0.7616145162145168,0.7365536723163841,0.20057441848122914,"['ARC', 'CRH']",0.999983391760135,0,0,2
397,Effects of nitric oxide WP1995,0.763387538174272,0.7366280711663372,0.19888181730190604,['XDH'],0.999983391760135,0,0,1
398,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.763387538174272,0.7366280711663372,0.19888181730190604,['CDKN1A'],0.999983391760135,0,0,1
399,Metastatic brain tumor WP2249,0.763387538174272,0.7366280711663372,0.19888181730190604,['MYC'],0.999983391760135,0,0,1
400,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.763387538174272,0.7366280711663372,0.19888181730190604,['SIX4'],0.999983391760135,0,0,1
401,miRNA Biogenesis WP2338,0.763387538174272,0.7366280711663372,0.19888181730190604,['RAN'],0.999983391760135,0,0,1
402,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.763387538174272,0.7366280711663372,0.19888181730190604,['ROBO4'],0.999983391760135,0,0,1
403,Somatic sex determination WP4814,0.763387538174272,0.7366280711663372,0.19888181730190604,['SOX9'],0.999983391760135,0,0,1
404,p38 MAPK Signaling Pathway WP400,0.7634502283667224,0.7889665481577246,0.2129478664869506,"['RPS6KA5', 'MYC', 'DDIT3', 'HSPB1', 'ELK1', 'HRAS']",0.999983391760135,0,0,6
405,Genotoxicity pathway WP4286,0.7656166359601239,0.8180445451113628,0.21847819141915628,"['IKBIP', 'PLK3', 'CDKN1A', 'RPS27', 'GADD45A', 'BLOC1S2', 'PCDH8', 'TRIAP1', 'HIST1H2BG', 'HIST1H2BC']",0.999983391760135,0,0,10
406,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7726276470854867,0.7364792314213054,0.18998074265799594,"['RAB27A', 'HRAS', 'MAPK3']",0.999983391760135,0,0,3
407,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7726276470854867,0.7364792314213054,0.18998074265799594,"['SUV39H1', 'CDC37', 'IGFBP7']",0.999983391760135,0,0,3
408,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7726276470854867,0.7364792314213054,0.18998074265799594,"['MDH2', 'IDH3B', 'SUCLG2']",0.999983391760135,0,0,3
409,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7727743707908455,0.767069550466497,0.19772610717135705,"['CDKN1B', 'BAD', 'TFEB', 'HRAS', 'FOXO1']",0.999983391760135,0,0,5
410,Non-small cell lung cancer WP4255,0.776488362761094,0.8249723962048446,0.20869625618312462,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'FHIT', 'EGFR', 'PLCG2', 'E2F1', 'CYCS', 'BAX', 'HRAS', 'RXRG', 'MAPK3']",0.999983391760135,0,0,13
411,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7804123870501649,0.7809180918091809,0.19361520724981413,"['LYN', 'HCK', 'CISH', 'MYC', 'RELB', 'MAPK3', 'NFKB2']",0.999983391760135,0,0,7
412,3q29 copy number variation syndrome WP4906,0.781907082257554,0.8097819314641744,0.19922203748968947,"['CASP7', 'TM4SF19', 'JUN', 'NCBP2', 'MYC', 'DYNLT3', 'MAD2L1BP', 'SLC51A', 'DYNLL1', 'DYNLL2', 'HAMP']",0.999983391760135,0,0,11
413,Gastric Cancer Network 1 WP2361,0.7857387784697685,0.7364047484454495,0.17756992849350833,"['NOTCH1', 'MCM4', 'GATD3B', 'GATD3A']",0.999983391760135,0,0,4
414,TLR4 Signaling and Tolerance WP3851,0.7857387784697685,0.7364047484454495,0.17756992849350833,"['INPP5D', 'IRF7', 'IRAK3', 'TLR4']",0.999983391760135,0,0,4
415,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7892550619453726,0.8239212217901138,0.19499392396757373,"['PDGFRA', 'BAD', 'HGF', 'GAB1', 'FGF2', 'EGFR', 'AXL', 'MYC', 'PDGFC', 'PLCG2', 'BCL2', 'BAX', 'HRAS', 'FGFR3', 'MAPK3']",0.999983391760135,0,0,15
416,Translation Factors WP107,0.7900403283920763,0.7887873519065141,0.18589452978295595,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF6', 'EIF1AX', 'EIF3I', 'EIF4H', 'EIF3CL', 'EIF1']",0.999983391760135,0,0,9
417,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7987915218416778,0.7363302233531241,0.1654204806842663,"['HPGD', 'PTGDR2', 'CYP4A11', 'TBXAS1', 'PTGDR']",0.999983391760135,0,0,5
418,Ganglio Sphingolipid Metabolism WP1423,0.8005836365575318,0.6695428864920391,0.1489158934083716,"['B3GALT1', 'FUT1']",0.999983391760135,0,0,2
419,Osteoclast Signaling WP12,0.8005836365575318,0.6695428864920391,0.1489158934083716,"['ATP6V1G1', 'GPR68']",0.999983391760135,0,0,2
420,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.8045531036060102,0.6903962983893756,0.1501393138362195,"['LDHA', 'PDHB', 'ACACB']",0.999983391760135,0,0,3
421,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8045531036060102,0.6903962983893756,0.1501393138362195,"['ELK1', 'HRAS', 'MAPK3']",0.999983391760135,0,0,3
422,Transcription factor regulation in adipogenesis WP3599,0.8045531036060102,0.6903962983893756,0.1501393138362195,"['CEBPB', 'LEP', 'FOXO1']",0.999983391760135,0,0,3
423,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8058139853926509,0.8488893752051647,0.18327721139159384,"['NOTCH2', 'NOTCH3', 'NOTCH1', 'EIF5A2', 'TWIST2', 'WNT8A', 'LRP5', 'CLDN2', 'FOXM1', 'DLL3', 'CLDN20', 'CDH1', 'HRAS', 'MAPK3', 'DSP', 'WNT10A', 'FZD2', 'MMP2', 'WNT16', 'TGFBR2', 'TJP1', 'CLDN5', 'CLDN10', 'LATS2', 'CLDN9', 'COL4A6', 'STRAP']",0.999983391760135,0,0,27
424,RANKL/RANK signaling pathway WP2018,0.80926075152162,0.7703842179055944,0.16303957097959457,"['LYN', 'JUN', 'VCAM1', 'SYK', 'NFATC1', 'ICAM1', 'RELB', 'MAPK3', 'NFKB2']",0.999983391760135,0,0,9
425,Nuclear receptors WP170,0.8112016772602264,0.7362556561085973,0.1540530869106421,"['NR4A1', 'NR1I3', 'RORA', 'PGR', 'PPARA', 'RXRG']",0.999983391760135,0,0,6
426,Oxysterols derived from cholesterol WP4545,0.8112016772602264,0.7362556561085973,0.1540530869106421,"['CYP39A1', 'ACOT11', 'THEM5', 'CYP3A4', 'ACOT6', 'ACOT4']",0.999983391760135,0,0,6
427,Glycosylation and related congenital defects WP4521,0.8128750501915012,0.7012840184123394,0.14529052993406988,"['DPM3', 'MPI', 'DOLK', 'MGAT2']",0.999983391760135,0,0,4
428,"Cerebral organic acidurias, including diseases WP4519",0.813925843196784,0.613809658288619,0.12637482687884857,['MDH2'],0.999983391760135,0,0,1
429,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.813925843196784,0.613809658288619,0.12637482687884857,['DHCR24'],0.999983391760135,0,0,1
430,Disorders of the Krebs cycle WP4236,0.813925843196784,0.613809658288619,0.12637482687884857,['SUCLG2'],0.999983391760135,0,0,1
431,Glial Cell Differentiation WP2276,0.813925843196784,0.613809658288619,0.12637482687884857,['MSN'],0.999983391760135,0,0,1
432,Mevalonate pathway WP3963,0.813925843196784,0.613809658288619,0.12637482687884857,['HMGCS1'],0.999983391760135,0,0,1
433,Molybdenum cofactor (Moco) biosynthesis WP4507,0.813925843196784,0.613809658288619,0.12637482687884857,['XDH'],0.999983391760135,0,0,1
434,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.813925843196784,0.613809658288619,0.12637482687884857,['MUC1'],0.999983391760135,0,0,1
435,Fluoropyrimidine Activity WP1601,0.8223990825091559,0.7079554598638568,0.1384261770242367,"['CDA', 'CYP2A6', 'DPYD', 'UPP2', 'ABCG2']",0.999983391760135,0,0,5
436,ESC Pluripotency Pathways WP3931,0.8248140260402743,0.8127949884150004,0.15654215357979015,"['PDGFRA', 'SMAD1', 'WNT10A', 'JUN', 'FZD2', 'GAB1', 'LRP5', 'LIFR', 'SMAD6', 'WNT16', 'FGF2', 'ELK1', 'EGFR', 'FGF17', 'BMPR1B', 'FGFR4', 'FGFR3', 'HRAS', 'FGF10']",0.999983391760135,0,0,19
437,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8326136991040973,0.6497348868906139,0.1190220042441577,"['B3GALNT1', 'B3GALT1', 'ST6GALNAC3']",0.999983391760135,0,0,3
438,Triacylglyceride synthesis WP325,0.8326136991040973,0.6497348868906139,0.1190220042441577,"['LPL', 'AGPAT1', 'PLPP3']",0.999983391760135,0,0,3
439,Wnt signaling pathway and pluripotency WP399,0.8411429841406544,0.7916545470868122,0.13695118323504735,"['TCF7L2', 'WNT10A', 'JUN', 'TCF7L1', 'PRKCH', 'FZD2', 'TCF7', 'LEF1', 'LRP5', 'PPM1J', 'WNT16', 'NKD1', 'FRAT1', 'CCND3', 'MYC', 'PRKD1', 'CD44']",0.999983391760135,0,0,17
440,Head and Neck Squamous Cell Carcinoma WP4674,0.8434430079014847,0.761297255055192,0.12962071303858855,"['NOTCH2', 'CDKN1A', 'NOTCH1', 'GAB1', 'E2F1', 'FADD', 'HRAS', 'FGFR3', 'EGFR', 'TGFBR2', 'PIK3R5', 'NFKB2']",0.999983391760135,0,0,12
441,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8437140843094162,0.6816825307071278,0.11584622299103083,"['SUPT4H1', 'NFATC3', 'NFATC2', 'NFATC1', 'NFATC4']",0.999983391760135,0,0,5
442,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8504457160757027,0.7180973677308929,0.11632796412251592,"['RPS6KA5', 'IL1R1', 'MYC', 'TOLLIP', 'MKNK2', 'IRF7', 'ELK1', 'MAPK3']",0.999983391760135,0,0,8
443,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8510383728959853,0.6901336255656109,0.11131721486907321,"['PRKCH', 'STAR', 'CYP11A1', 'HSD3B1', 'HRAS', 'MAPK3']",0.999983391760135,0,0,6
444,Canonical NF-KB pathway WP4562,0.8536719336579814,0.5260822205188204,0.08323057988389984,['NFKBIE'],0.999983391760135,0,0,1
445,Disorders of Folate Metabolism and Transport WP4259,0.8536719336579814,0.5260822205188204,0.08323057988389984,['ALDH1L1'],0.999983391760135,0,0,1
446,Liver X receptor pathway WP2874,0.8536719336579814,0.5260822205188204,0.08323057988389984,['CYP3A4'],0.999983391760135,0,0,1
447,Methylation Pathways WP704,0.8536719336579814,0.5260822205188204,0.08323057988389984,['MAT2B'],0.999983391760135,0,0,1
448,Mitochondrial CII Assembly WP4920,0.8536719336579814,0.5260822205188204,0.08323057988389984,['SDHAF1'],0.999983391760135,0,0,1
449,Ebola Virus Pathway on Host WP4217,0.8558614843149012,0.7962534073907073,0.12393424175797038,"['VPS18', 'HLA-DRB5', 'CAV3', 'CD300A', 'ICAM2', 'MERTK', 'ASGR1', 'EGFR', 'ACTG1', 'HLA-E', 'NFKB2', 'RELB', 'BST2', 'SOCS3', 'SCIN', 'AXL', 'NEDD4', 'IRF7', 'ITGA6', 'TLR4', 'MAPK3']",0.999983391760135,0,0,21
450,Purine metabolism and related disorders WP4224,0.8571326747599352,0.6135914100028257,0.09459282215787397,"['PRPS1', 'XDH', 'APRT']",0.999983391760135,0,0,3
451,Nucleotide Excision Repair WP4753,0.8585167308307452,0.6962804388546963,0.1062169615283194,"['POLE4', 'POLD4', 'CETN2', 'POLD1', 'RPA3', 'POLE3', 'POLE']",0.999983391760135,0,0,7
452,One-carbon metabolism and related pathways WP3940,0.8585167308307452,0.6962804388546963,0.1062169615283194,"['DMGDH', 'GPX4', 'GPX3', 'GAD1', 'DNMT3A', 'SOD3', 'SOD1']",0.999983391760135,0,0,7
453,Regulation of Microtubule Cytoskeleton WP2038,0.8585167308307452,0.6962804388546963,0.1062169615283194,"['SPRED1', 'PARD6A', 'CFL2', 'STMN1', 'RHO', 'CDK1', 'PHLDB2']",0.999983391760135,0,0,7
454,Intraflagellar transport proteins binding to dynein WP4532,0.858682579164282,0.6402044879199744,0.09753896228696432,"['IFT140', 'DYNLT3', 'DYNLL1', 'DYNLL2']",0.999983391760135,0,0,4
455,Monoamine Transport WP727,0.858682579164282,0.6402044879199744,0.09753896228696432,"['ADORA2A', 'IL1R1', 'TGFB1I1', 'IL1B']",0.999983391760135,0,0,4
456,IL-1 signaling pathway WP195,0.8589361949402066,0.7199756334682927,0.10947995421050857,"['JUN', 'IL1R1', 'IL1B', 'TOLLIP', 'PELI2', 'PELI1', 'CCL2', 'IRAK3', 'MAPK3']",0.999983391760135,0,0,9
457,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8619026344504961,0.5664493698392004,0.08418172194426567,"['FRAT1', 'SOX9']",0.999983391760135,0,0,2
458,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.8619026344504961,0.5664493698392004,0.08418172194426567,"['ACLY', 'SUCLG2']",0.999983391760135,0,0,2
459,MAPK Cascade WP422,0.8628701584778337,0.657286239347308,0.0969438394939025,"['JUN', 'ELK1', 'HRAS', 'SIPA1', 'MAPK3']",0.999983391760135,0,0,5
460,Wnt Signaling Pathway WP363,0.8658767920681223,0.7009459131700219,0.10094508055113385,"['TCF7L2', 'GSK3A', 'FRAT1', 'GJA1', 'MYC', 'LEF1', 'LRP5', 'NFATC2']",0.999983391760135,0,0,8
461,Regulation of Actin Cytoskeleton WP51,0.8692124430578745,0.7993472697827941,0.11204268043543038,"['CHRM1', 'BRK1', 'FGF2', 'EGFR', 'ACTG1', 'PIK3R5', 'CFL2', 'TMSB4X', 'CFL1', 'RAC3', 'PIP4K2C', 'WASF2', 'MAPK3', 'PDGFRA', 'MSN', 'GNG12', 'F2', 'FGF17', 'VIL1', 'DIAPH3', 'EZR', 'FGFR4', 'FGFR3', 'DOCK1', 'FGF10']",0.999983391760135,0,0,25
462,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8740378048480071,0.6779051589369464,0.09126748960800597,"['ADCY10', 'ADCY9', 'CFL1', 'ADCY4', 'BANF1', 'HRAS', 'MAPK3']",0.999983391760135,0,0,7
463,MECP2 and Associated Rett Syndrome WP3584,0.8744418731554509,0.7226858032932799,0.09696236064897695,"['GABRR2', 'ARHGEF26', 'BCL6', 'BDNF', 'SST', 'GAD1', 'E2F1', 'SGK1', 'FGF2', 'MYT1', 'FKBP5']",0.999983391760135,0,0,11
464,Fatty Acid Biosynthesis WP357,0.8784439196909194,0.5812525096295414,0.0753321909689639,"['ACLY', 'ECHDC3', 'ACACB']",0.999983391760135,0,0,3
465,Hippo-Yap signaling pathway WP4537,0.8784439196909194,0.5812525096295414,0.0753321909689639,"['LATS2', 'TEAD2', 'TEAD3']",0.999983391760135,0,0,3
466,NAD+ biosynthetic pathways WP3645,0.8784439196909194,0.5812525096295414,0.0753321909689639,"['PARP4', 'CD38', 'ACMSD']",0.999983391760135,0,0,3
467,NRF2-ARE regulation WP4357,0.8784439196909194,0.5812525096295414,0.0753321909689639,"['CEBPB', 'HMOX1', 'SLC7A11']",0.999983391760135,0,0,3
468,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8784439196909194,0.5812525096295414,0.0753321909689639,"['GNA14', 'CA8', 'RYR3']",0.999983391760135,0,0,3
469,p53 transcriptional gene network WP4963,0.8797875805968465,0.7075420332781601,0.09061829473407072,"['CDKN1A', 'NOTCH1', 'ADORA2B', 'GADD45A', 'CCL2', 'PMAIP1', 'BAX', 'SLC7A11', 'ICAM1', 'TNFRSF10D']",0.999983391760135,0,0,10
470,Cardiac Hypertrophic Response WP2795,0.8799858731910193,0.6845922006817494,0.08752471910078746,"['NPPA', 'NFATC2', 'PRKD1', 'CALM1', 'FGF2', 'CALM2', 'PRKG1', 'MAPK3']",0.999983391760135,0,0,8
471,Aspirin and miRNAs WP4707,0.8849299195784887,0.46028664219147136,0.05626858014978412,['PPARA'],0.999983391760135,0,0,1
472,ATR Signaling WP3875,0.8849299195784887,0.46028664219147136,0.05626858014978412,['RAD9A'],0.999983391760135,0,0,1
473,Biotin Metabolism (including IEMs) WP5031,0.8849299195784887,0.46028664219147136,0.05626858014978412,['ACACB'],0.999983391760135,0,0,1
474,"Degradation pathway of sphingolipids, including diseases WP4153",0.8849299195784887,0.46028664219147136,0.05626858014978412,['NEU1'],0.999983391760135,0,0,1
475,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.8849299195784887,0.46028664219147136,0.05626858014978412,['TIFA'],0.999983391760135,0,0,1
476,NLR Proteins WP288,0.8849299195784887,0.46028664219147136,0.05626858014978412,['ERBIN'],0.999983391760135,0,0,1
477,Supression of HMGB1 mediated inflammation by THBD WP4479,0.8849299195784887,0.46028664219147136,0.05626858014978412,['THBD'],0.999983391760135,0,0,1
478,Urea cycle and related diseases WP4571,0.8849299195784887,0.46028664219147136,0.05626858014978412,['SLC25A15'],0.999983391760135,0,0,1
479,Vitamin D Metabolism WP1531,0.8849299195784887,0.46028664219147136,0.05626858014978412,['GC'],0.999983391760135,0,0,1
480,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8855946767987389,0.5259483454398709,0.0639005720255754,"['MKNK2', 'MAPK3']",0.999983391760135,0,0,2
481,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8855946767987389,0.5259483454398709,0.0639005720255754,"['RAB27A', 'SYTL4']",0.999983391760135,0,0,2
482,Mammalian disorder of sexual development WP4842,0.8855946767987389,0.5259483454398709,0.0639005720255754,"['FST', 'SOX9']",0.999983391760135,0,0,2
483,G Protein Signaling Pathways WP35,0.8908121844161128,0.7355826481428976,0.08504929098840507,"['PRKCH', 'ADCY4', 'AKAP5', 'GNG12', 'GNG11', 'GNA14', 'GNG10', 'GNG3', 'ADCY9', 'PRKAR1A', 'PRKD1', 'PDE7B', 'CALM1', 'HRAS', 'CALM2']",0.999983391760135,0,0,15
484,PDGFR-beta pathway WP3972,0.8945506065181719,0.5888976823063878,0.06562310798261532,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.999983391760135,0,0,4
485,Estrogen signaling pathway WP712,0.8968785808437321,0.5521474992935858,0.06009285573425527,"['JUN', 'BCL2', 'ELK1']",0.999983391760135,0,0,3
486,16p11.2 proximal deletion syndrome WP4949,0.8971399728545675,0.6976581802556665,0.07572617944726084,"['SPN', 'PARP4', 'MSN', 'GDPD3', 'TBX6', 'EZR', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'MAPK3']",0.999983391760135,0,0,11
487,IL-6 signaling pathway WP364,0.897636733946069,0.6308338720103426,0.06812363655521925,"['SOCS3', 'HCK', 'BAD', 'GAB1', 'VIP', 'MAPK3']",0.999983391760135,0,0,6
488,Amino Acid metabolism WP3925,0.8981675469787146,0.7136603748049213,0.07664616092397,"['AOC3', 'TPH1', 'GOT1', 'MDH2', 'ODC1', 'ACLY', 'TPO', 'LDHA', 'PKM', 'ALDH1A1', 'PDK4', 'ACSS1', 'HIBCH']",0.999983391760135,0,0,13
489,Canonical and non-canonical TGF-B signaling WP3874,0.9054681701466358,0.4908474576271186,0.048742700657766175,"['LOXL1', 'TGFBR2']",0.999983391760135,0,0,2
490,Pyrimidine metabolism and related diseases WP4225,0.9054681701466358,0.4908474576271186,0.048742700657766175,"['NT5C', 'DPYD']",0.999983391760135,0,0,2
491,Proteasome Degradation WP183,0.9084211261012917,0.6621737899801868,0.06359994680747456,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMD2', 'NEDD4', 'PSMB10', 'HLA-E']",0.999983391760135,0,0,9
492,Type II interferon signaling (IFNG) WP619,0.9092827303786641,0.5662042875157629,0.05384557401261288,"['SOCS3', 'IL1B', 'GBP1', 'ICAM1']",0.999983391760135,0,0,4
493,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.9095120992444059,0.4091123034924221,0.03880306562025041,['MAFK'],0.999983391760135,0,0,1
494,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.9095120992444059,0.4091123034924221,0.03880306562025041,['HMOX1'],0.999983391760135,0,0,1
495,Non-homologous end joining WP438,0.9095120992444059,0.4091123034924221,0.03880306562025041,['DCLRE1C'],0.999983391760135,0,0,1
496,TCA cycle in senescence WP5050,0.9095120992444059,0.4091123034924221,0.03880306562025041,['GOT1'],0.999983391760135,0,0,1
497,Valproic acid pathway WP3871,0.9095120992444059,0.4091123034924221,0.03880306562025041,['CYP2A6'],0.999983391760135,0,0,1
498,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9123322360473448,0.6281574498913306,0.05763411271311693,"['ARC', 'HOMER1', 'BDNF', 'PRKAG2', 'GRIN2C', 'HRAS', 'MAPK3']",0.999983391760135,0,0,7
499,miRNA regulation of p53 pathway in prostate cancer WP3982,0.9127556451155746,0.5258143947039116,0.04800005741864968,"['TNFRSF10B', 'PMAIP1', 'BAX']",0.999983391760135,0,0,3
500,MTHFR deficiency WP4288,0.9127556451155746,0.5258143947039116,0.04800005741864968,"['DNMT3A', 'EHMT1', 'CYCS']",0.999983391760135,0,0,3
501,Urea cycle and associated pathways WP4595,0.9127556451155746,0.5258143947039116,0.04800005741864968,"['SLC25A15', 'GOT1', 'MDH2']",0.999983391760135,0,0,3
502,G13 Signaling Pathway WP524,0.920847301228429,0.5749487560079163,0.04741087994748946,"['CFL2', 'CFL1', 'ARHGDIG', 'CALM1', 'CALM2']",0.999983391760135,0,0,5
503,ATM Signaling Network in Development and Disease  WP3878,0.9212369851028659,0.5966430231136114,0.04894737826085974,"['DCLRE1C', 'KAT5', 'CDK5', 'CDK1', 'HSPB1', 'CDK5R1']",0.999983391760135,0,0,6
504,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9246758124227813,0.6261363773194139,0.049034039539577606,"['YAP1', 'DCLRE1C', 'RAD51', 'KAT5', 'CDK5', 'E2F1', 'BAX', 'RAD9A']",0.999983391760135,0,0,8
505,EPO Receptor Signaling WP581,0.926375676416371,0.5018752087132986,0.0383811216576103,"['PTPRC', 'CISH', 'MAPK3']",0.999983391760135,0,0,3
506,Integrated breast cancer pathway WP1984,0.9269825462682953,0.7468948729862619,0.05662997392481984,"['GSK3A', 'ODC1', 'PHB', 'JAKMIP1', 'TFPI', 'FOXO1', 'EGFR', 'CDH1', 'MYC', 'E2F1', 'RHO', 'FADD', 'SMAD1', 'PLK3', 'JUN', 'GADD45A', 'BAD', 'SMAD6', 'MYT1', 'TGFBR2', 'RAD51', 'CDK2', 'BCL2', 'BAX', 'FAU']",0.999983391760135,0,0,25
507,Ras signaling WP4223,0.9319299665071081,0.755600777658666,0.05326804920554496,"['CSF1R', 'FLT1', 'RASAL3', 'ELK1', 'ETS2', 'EGFR', 'GNG10', 'GNG3', 'PLCG2', 'RAC3', 'HRAS', 'MAPK3', 'NTRK1', 'PDGFRA', 'NGFR', 'PLA2G12B', 'BAD', 'GAB1', 'GNG12', 'GNG11', 'RASA4', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'FGFR3', 'PLA1A', 'EPHA2', 'ARF6']",0.999983391760135,0,0,29
508,Ebstein-Barr virus LMP1 signaling WP262,0.9358990040993774,0.4330342306414091,0.02868752610110703,"['HSP90AA1', 'NFKB2']",0.999983391760135,0,0,2
509,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9358990040993774,0.4330342306414091,0.02868752610110703,"['DNMT3A', 'BCL2']",0.999983391760135,0,0,2
510,Ectoderm Differentiation WP2858,0.939503457902036,0.7145460569913851,0.044590374624849605,"['TFAP2C', 'TCF7L1', 'EDA', 'ARHGDIG', 'STC1', 'PRKAG2', 'NFATC1', 'PAX6', 'JAKMIP1', 'PTPN13', 'ZFHX4', 'VAX2', 'EDA2R', 'GLI3', 'PPFIBP2', 'MAFB', 'MYC', 'BOC', 'CCL2', 'CTNNA2', 'LY6E']",0.999983391760135,0,0,21
511,PDGF Pathway WP2526,0.9407195258644344,0.5410450863975785,0.03306339696373218,"['JUN', 'ARFIP2', 'ELK1', 'HRAS', 'MAPK3']",0.999983391760135,0,0,5
512,MET in type 1 papillary renal cell carcinoma WP4205,0.9410313844787064,0.6004873935992053,0.036496895806542175,"['CDKN1A', 'JUN', 'BAD', 'HGF', 'RPL11', 'GAB1', 'HRAS', 'MAPK3']",0.999983391760135,0,0,8
513,Pathways affected in adenoid cystic carcinoma WP3651,0.9423555562550714,0.6129351825643928,0.036391572194921444,"['NOTCH1', 'MYCBP', 'UHRF1', 'MYC', 'INSRR', 'ERBIN', 'IL17RD', 'FGFR4', 'HRAS']",0.999983391760135,0,0,9
514,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.9476958117792917,0.5517675339366516,0.029641890958926373,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'DDIT3', 'BCL2']",0.999983391760135,0,0,6
515,Histone Modifications WP2369,0.9476958117792917,0.5517675339366516,0.029641890958926373,"['SET', 'H3F3B', 'SUV39H1', 'EHMT1', 'SMYD1', 'HIST1H3E']",0.999983391760135,0,0,6
516,Nanoparticle-mediated activation of receptor signaling WP2643,0.947933757667242,0.4599816332297259,0.024595519238375406,"['COL1A1', 'HRAS', 'EGFR']",0.999983391760135,0,0,3
517,Common Pathways Underlying Drug Addiction WP2636,0.948863420627449,0.5255462660042812,0.02758613896818338,"['DRD2', 'CALM1', 'CALM2', 'ACTG1', 'MAPK3']",0.999983391760135,0,0,5
518,Wnt signaling in kidney disease WP4150,0.9514922104306005,0.49055963821368004,0.02439247898777004,"['WNT10A', 'FZD2', 'LRP5', 'WNT16']",0.999983391760135,0,0,4
519,Glioblastoma signaling pathways WP2261,0.9530677468597339,0.6302063941723999,0.03029357383249552,"['PDGFRA', 'CDKN1A', 'CDKN1B', 'PRKCH', 'CDK2', 'GAB1', 'PLCG2', 'E2F1', 'HRAS', 'FOXO1', 'EGFR', 'MAPK3']",0.999983391760135,0,0,12
520,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9540199467620384,0.7040849673202615,0.03314177170574581,"['NSF', 'VAV3', 'NTRK1', 'NGFR', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'NCF1', 'BDNF', 'BAD', 'ELK1', 'ACACB', 'NFATC4', 'RPS6KA5', 'CDK5', 'CFL1', 'NTF3', 'IGF2BP1', 'ALPL', 'HRAS', 'MAPK3', 'CDK5R1']",0.999983391760135,0,0,23
521,Kit receptor signaling pathway WP304,0.9541732177034391,0.5768500948766604,0.027060069155904115,"['LYN', 'BAD', 'INPP5D', 'BCL2', 'PTPN6', 'HRAS', 'MAPK3', 'TBX2']",0.999983391760135,0,0,8
522,Osteopontin Signaling WP1434,0.9560016636084113,0.3067636260943236,0.013803021315320511,['MAPK3'],0.999983391760135,0,0,1
523,16p11.2 distal deletion syndrome WP4950,0.9563552909569697,0.4415484600169539,0.019704449607717417,"['PLN', 'SLN', 'NFATC2']",0.999983391760135,0,0,3
524,Autophagy WP4923,0.9563552909569697,0.4415484600169539,0.019704449607717417,"['ATG101', 'ATG9A', 'PRKAG2']",0.999983391760135,0,0,3
525,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9567375449333692,0.6127159444916455,0.02709808127546765,"['EDN1', 'FZD2', 'CISH', 'NPPA', 'LRP5', 'CALM1', 'FGF2', 'CALM2', 'PRKG1', 'MAPK3', 'NFATC4']",0.999983391760135,0,0,11
526,T-cell receptor (TCR) signaling pathway WP69,0.9567375449333692,0.6127159444916455,0.02709808127546765,"['VAV3', 'JUN', 'FYB1', 'IL1B', 'NFATC2', 'NFATC1', 'CD247', 'VIM', 'HRAS', 'CARD11', 'MAPK3']",0.999983391760135,0,0,11
527,Kallmann's Syndrome WP5074,0.9568742339617947,0.38739220933690155,0.01707753206947198,"['PROKR2', 'CHD7']",0.999983391760135,0,0,2
528,MAPK Signaling Pathway WP382,0.9594484310648885,0.7528005974607916,0.03116346848161695,"['HSPB1', 'ELK1', 'FGF2', 'EGFR', 'RELB', 'RPS6KA5', 'MYC', 'STMN1', 'NTF3', 'MKNK2', 'RAC3', 'CACNG1', 'HRAS', 'CACNG4', 'CACNG5', 'MAPK3', 'DUSP4', 'NTRK1', 'HSPA8', 'JUN', 'DUSP2', 'DUSP3', 'IL1R1', 'GADD45A', 'BDNF', 'IL1R2', 'NFATC3', 'NFATC1', 'GNG12', 'DUSP6', 'NFKB2', 'TGFBR2', 'FGF17', 'NR4A1', 'DDIT3', 'IL1B', 'PTPN7', 'FGFR4', 'FGFR3', 'FGF10']",0.999983391760135,0,0,40
529,Chemokine signaling pathway WP3929,0.9610533883902859,0.6826650715177959,0.027119086041998624,"['LYN', 'CCR1', 'VAV3', 'CX3CR1', 'NCF1', 'CXCR5', 'ADCY4', 'CXCR4', 'PRKX', 'GNG12', 'GNG11', 'CXCL5', 'PIK3R5', 'FGR', 'HCK', 'GNG10', 'GNG3', 'ADCY9', 'PARD3', 'HRAS', 'MAPK3']",0.999983391760135,0,0,21
530,Integrin-mediated Cell Adhesion WP185,0.9646951299601347,0.6274196670538134,0.02255144238136734,"['VAV3', 'CAV3', 'ITGB5', 'ITGB4', 'CAPNS1', 'ITGA10', 'ITGA8', 'RHO', 'RAC3', 'ITGB8', 'ITGA6', 'HRAS', 'DOCK1', 'TNS1']",0.999983391760135,0,0,14
531,Eicosanoid Synthesis WP167,0.9647172095551424,0.3679943502824859,0.013218455567962984,"['PTGES2', 'TBXAS1']",0.999983391760135,0,0,2
532,Nanoparticle triggered autophagic cell death WP2509,0.9647172095551424,0.3679943502824859,0.013218455567962984,"['MAP1LC3A', 'BCL2']",0.999983391760135,0,0,2
533,IL-9 signaling pathway WP22,0.9654029211515379,0.2831447005409163,0.009969448432773222,['MAPK3'],0.999983391760135,0,0,1
534,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.9654029211515379,0.2831447005409163,0.009969448432773222,['CGAS'],0.999983391760135,0,0,1
535,Riboflavin and CoQ disorders WP5037,0.9654029211515379,0.2831447005409163,0.009969448432773222,['RFK'],0.999983391760135,0,0,1
536,Pancreatic adenocarcinoma pathway WP4263,0.9664695369040114,0.6041677985175987,0.020605444738979944,"['CDKN1A', 'RAD51', 'GADD45B', 'BAD', 'GADD45A', 'E2F1', 'RAC3', 'BAX', 'DUSP6', 'EGFR', 'TGFBR2', 'MAPK3']",0.999983391760135,0,0,12
537,Interleukin-11 Signaling Pathway WP2332,0.967563826946528,0.4839441691591149,0.01595751950127274,"['SOCS3', 'BCL2', 'HRAS', 'ICAM1', 'MAPK3']",0.999983391760135,0,0,5
538,Prolactin Signaling Pathway WP2037,0.969112224764896,0.5743470413363534,0.01802005730492044,"['SOCS3', 'JUN', 'CISH', 'MYC', 'PTPN6', 'ELK1', 'HRAS', 'PRLR', 'YWHAG', 'MAPK3']",0.999983391760135,0,0,10
539,Phosphoinositides metabolism WP4971,0.9703306323791652,0.44586052726244924,0.013428609021856084,"['PIP4P1', 'INPP5D', 'PLCG2', 'PIP4K2C']",0.999983391760135,0,0,4
540,Sphingolipid Metabolism (general overview) WP4725,0.971177977177762,0.3504439063761098,0.01024891946701431,"['CERS4', 'PLPP3']",0.999983391760135,0,0,2
541,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9722334956009542,0.47149909745329593,0.013277075839839626,"['ABCA1', 'IDI1', 'HMGCS1', 'MSMO1', 'DHCR24']",0.999983391760135,0,0,5
542,Cell Differentiation - Index expanded WP2023,0.9727957260667456,0.2628999072094243,0.007251084724036865,['KLF4'],0.999983391760135,0,0,1
543,GPR40 Pathway WP3958,0.9727957260667456,0.2628999072094243,0.007251084724036865,['PLCG2'],0.999983391760135,0,0,1
544,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9763116171897555,0.5251435039210931,0.012589508686789718,"['ACLY', 'IDI1', 'GSK3A', 'RBP4', 'HMGCS1', 'PRKAG2', 'LPL', 'ACSS1']",0.999983391760135,0,0,8
545,ErbB signaling pathway WP673,0.9763407866039848,0.5801848814671239,0.01389170713389874,"['CDKN1A', 'JUN', 'CDKN1B', 'BAD', 'MYC', 'GAB1', 'PLCG2', 'ELK1', 'HRAS', 'FOXO1', 'EGFR', 'MAPK3']",0.999983391760135,0,0,12
546,Sphingolipid Metabolism (integrated pathway) WP4726,0.976489045905186,0.3344889573703133,0.007958076460515514,"['CERS4', 'PLPP3']",0.999983391760135,0,0,2
547,TGF-beta Signaling Pathway WP366,0.9783125800545716,0.6342812169380435,0.013907280728048574,"['KLF10', 'YAP1', 'JUN', 'CDKN1A', 'CITED1', 'ITGB4', 'TGFB1I1', 'LIMK2', 'NEDD9', 'TGFBR2', 'TGFBR3', 'DAB2', 'COL1A2', 'PARD6A', 'SUMO1', 'MYC', 'CDK1', 'STRAP', 'SKP1']",0.999983391760135,0,0,19
548,Glycosaminoglycan degradation WP4815,0.9786090597287694,0.24535441965546456,0.005305309000413641,['HPSE2'],0.999983391760135,0,0,1
549,NAD+ metabolism WP3644,0.9786090597287694,0.24535441965546456,0.005305309000413641,['CD38'],0.999983391760135,0,0,1
550,Signal Transduction of S1P Receptor WP26,0.9808466795315784,0.31992139523458607,0.0061869987678678335,"['S1PR1', 'MAPK3']",0.999983391760135,0,0,2
551,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9831802988552453,0.2300021180457498,0.003901470431318695,['ACSF2'],0.999983391760135,0,0,1
552,Target Of Rapamycin (TOR) Signaling WP1471,0.9854169595669604,0.35592339735117445,0.005228663545382999,"['IDI1', 'RRAGA', 'PRKAG2']",0.999983391760135,0,0,3
553,Joubert Syndrome WP4656,0.9859093756582957,0.5087765899540595,0.007219967031480631,"['TMEM17', 'KAT5', 'CETN2', 'SUFU', 'BBS9', 'ARL2', 'PDE6A', 'ARR3', 'ZNF423']",0.999983391760135,0,0,9
554,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9867747721412952,0.2164559695665897,0.002881777887104276,['MAP1LC3A'],0.999983391760135,0,0,1
555,AMP-activated protein kinase (AMPK) signaling WP1403,0.9871303098414772,0.46775877587758774,0.006058983304514681,"['GYS2', 'GYS1', 'CDKN1A', 'LEP', 'LEPR', 'PRKAG2', 'ACACB']",0.999983391760135,0,0,7
556,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9873708820877762,0.38704590758977714,0.004919176633301495,"['MAP1LC3A', 'ATG101', 'CP', 'FTL']",0.999983391760135,0,0,4
557,EGF/EGFR signaling pathway WP437,0.9873952100846694,0.6298409911228173,0.007989472638384777,"['VAV3', 'NDUFA13', 'JUN', 'LIMK2', 'GAB1', 'NEDD8', 'ELK1', 'FOXO1', 'EPN1', 'EGFR', 'EPS8', 'GJA1', 'PLSCR1', 'RPS6KA5', 'INPP5D', 'NEDD4', 'CFL1', 'STMN1', 'E2F1', 'AP2S1', 'HRAS', 'AP2M1', 'ARF6']",0.999983391760135,0,0,23
558,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.987917477129934,0.3447743006499011,0.004191114287610668,"['MAP1LC3A', 'MSTN', 'TNFSF9']",0.999983391760135,0,0,3
559,Resistin as a regulator of inflammation WP4481,0.989717238310103,0.28294219904389395,0.0029244890184084976,"['PLCG2', 'MAPK3']",0.999983391760135,0,0,2
560,Thermogenesis WP4321,0.9910892333685839,0.5363393519506114,0.004800615288843962,"['UCP1', 'ADCY4', 'PRKAG2', 'ACTG1', 'ADCY10', 'CREB3', 'ADCY9', 'CREB3L1', 'PRDM16', 'ZNF516', 'DPF3', 'HRAS', 'PRKG1']",0.999983391760135,0,0,13
561,Ciliary landscape WP4352,0.9911252870733694,0.6553916185201102,0.005842375689244506,"['YAP1', 'DOCK5', 'SSNA1', 'USH1C', 'COPS7A', 'MYL6B', 'PSMD8', 'PSMD7', 'EXOSC4', 'ARHGDIA', 'CDH23', 'NEFL', 'BBS9', 'STOM', 'NEFM', 'DCAF11', 'TFAP2C', 'NDUFA5', 'IFT140', 'WHRN', 'DYNLT3', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'MKLN1', 'MCM4', 'EFHC2', 'VIM', 'CALM1', 'COPS8', 'CALM2']",0.999983391760135,0,0,32
562,Sphingolipid pathway WP1422,0.9916602079283156,0.2724419334588826,0.0022816365436612194,"['CERS4', 'SERINC1']",0.999983391760135,0,0,2
563,Vitamin D in inflammatory diseases WP4482,0.9918235089199539,0.19364140370695165,0.0015898156605819525,['NFATC1'],0.999983391760135,0,0,1
564,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9925676687331528,0.3586427497966331,0.0026755067111674923,"['EIF4A2', 'RPS6KA5', 'PIM2', 'MAPK3']",0.999983391760135,0,0,4
565,DNA IR-damage and cellular response via ATR WP4016,0.9929761584909909,0.4722534470906959,0.0033287373596347395,"['FEN1', 'BRIP1', 'RAD51', 'BCL6', 'CDK2', 'E2F1', 'CDK1', 'FOXM1', 'RAD9A']",0.999983391760135,0,0,9
566,Glycerolipids and Glycerophospholipids WP4722,0.9935709173072594,0.18394521321660548,0.0011864168725084535,['CDIPT'],0.999983391760135,0,0,1
567,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9936133464619824,0.38282796154933557,0.002452830608902589,"['TKFC', 'CASP10', 'IRF7', 'PIN1', 'FADD']",0.999983391760135,0,0,5
568,Energy Metabolism WP1541,0.9937877130409902,0.3500767180812404,0.0021815603075829026,"['UCP3', 'PRKAG2', 'PPARA', 'FOXO1']",0.999983391760135,0,0,4
569,Male infertility WP4673,0.9946294660298005,0.5131125513030284,0.0027631147473026877,"['MMP2', 'PON2', 'HMGA1', 'PEX10', 'TEX15', 'SOD3', 'ETV5', 'CYP26B1', 'SPATA17', 'MSH4', 'BCL2', 'AHRR', 'SOX5']",0.999983391760135,0,0,13
570,Immune response to tuberculosis WP4197,0.9949448504762014,0.1751724694396256,0.000887768822878715,['IFIT3'],0.999983391760135,0,0,1
571,Fatty acid beta-oxidation WP143,0.9955746327918125,0.2451412429378531,0.001087247530970691,"['TPI1', 'LPL']",0.999983391760135,0,0,2
572,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9964230458400384,0.23721523601239292,0.0008500291909260638,"['JUN', 'TLR7']",0.999983391760135,0,0,2
573,DNA Repair Pathways Full Network WP4946,0.997787217797127,0.4891156462585034,0.0010835056207614173,"['FEN1', 'DCLRE1C', 'CENPX', 'CETN2', 'POLE4', 'POLD4', 'BRIP1', 'NEIL2', 'RAD51', 'POLD1', 'RPA3', 'APEX1', 'POLE3', 'POLE']",0.999983391760135,0,0,14
574,Interferon type I signaling pathways WP585,0.9979310643635599,0.306175805539853,0.0006341142322913712,"['SOCS3', 'RPS6KA5', 'PTPRC', 'PTPN6']",0.999983391760135,0,0,4
575,Insulin Signaling WP481,0.998115424937141,0.5351140070547176,0.0010094139707172171,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'SNAP23', 'GAB1', 'ELK1', 'FOXO1', 'GYS2', 'SOCS3', 'GYS1', 'RPS6KA5', 'RHOJ', 'SGK1', 'HRAS', 'PFKM', 'ARF6', 'MAPK3']",0.999983391760135,0,0,20
576,Ciliopathies WP4803,0.9985177767290123,0.5471946354299295,0.0008116663064495582,"['EVC2', 'DNAH11', 'RSPH4A', 'IFT140', 'DNAH6', 'CFAP410', 'CCDC28B', 'GLI3', 'GLI2', 'RP1L1', 'TMEM17', 'SMO', 'ZIC2', 'MAK', 'SUFU', 'HYDIN', 'BBS9', 'NEK2', 'CCDC65', 'CCNQ', 'ZNF423', 'CCDC151', 'CCNO']",0.999983391760135,0,0,23
577,Fragile X Syndrome  WP4549,0.9987677893660994,0.4584514026636441,0.0005652570229112979,"['GABRA1', 'DUSP3', 'HOMER1', 'BDNF', 'GAD1', 'GAB1', 'AKAP5', 'ARC', 'PRKAR1A', 'AP2S1', 'GABRD', 'AP2M1', 'SHANK1']",0.999983391760135,0,0,13
578,Glycerophospholipid Biosynthetic Pathway WP2533,0.9988045171509723,0.13618249709749286,0.00016290123184505695,['CDIPT'],0.999983391760135,0,0,1
579,Rett syndrome causing genes WP4312,0.9990520230523335,0.24492794574738627,0.0002322961695192211,"['CECR2', 'KCNJ10', 'GABRD']",0.999983391760135,0,0,3
580,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9990596306576024,0.13130875055472627,0.00012353681763604076,['BAX'],0.999983391760135,0,0,1
581,Splicing factor NOVA regulated synaptic proteins WP4148,0.9993623761418878,0.18843980877879182,0.00012019204062522846,"['CADM1', 'NCDN']",0.999983391760135,0,0,2
582,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.999939072317821,0.3565737600970419,2.1725874588884156e-05,"['SLCO1C1', 'GYS1', 'GSK3A', 'RPS6KA5', 'TRIP10', 'LPL', 'PRKAG2', 'CYP3A4', 'HRAS', 'FOXO1', 'MAPK3']",0.999983391760135,0,0,11
583,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999833595406642,0.2671410891089109,4.44538741698603e-06,"['EVC2', 'TMEM17', 'IFT140', 'CDK20', 'BBS9', 'TULP3', 'DYNLL1']",0.999983391760135,0,0,7
584,mRNA Processing WP411,0.999983391760135,0.31561194204709647,5.24180236646711e-06,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'CSTF2T', 'SNRPE', 'SNU13', 'SRSF9', 'LSM2']",0.999983391760135,0,0,10
